0001144204-19-024259.txt : 20190507 0001144204-19-024259.hdr.sgml : 20190507 20190507164316 ACCESSION NUMBER: 0001144204-19-024259 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 49 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190507 DATE AS OF CHANGE: 20190507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Semler Scientific, Inc. CENTRAL INDEX KEY: 0001554859 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 261367393 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36305 FILM NUMBER: 19803726 BUSINESS ADDRESS: STREET 1: 911 BERN COURT, SUITE 110 CITY: SAN JOSE STATE: CA ZIP: 95112 BUSINESS PHONE: 408-627-4557 MAIL ADDRESS: STREET 1: 911 BERN COURT, SUITE 110 CITY: SAN JOSE STATE: CA ZIP: 95112 10-Q/A 1 tv520855_10qa.htm 10-Q/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

Amendment No. 1

 

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended March 31, 2019

 

OR

 

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Transition Period from ___ to ___

 

Commission File Number 001-36305

 

SEMLER SCIENTIFIC, INC.

(Exact name of registrant as specified in its charter)

 

Delaware 26-1367393
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)

 

911 Bern Court, Suite 110

San Jose, CA 95112

(Address of principal executive offices) (Zip Code)

(877) 774-4211

(Registrant's telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x  No ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x  No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

 

Large Accelerated Filer ¨   Accelerated Filer ¨
         
Non-Accelerated Filer ¨   Smaller Reporting Company x
         
Emerging growth company x      

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ¨    No x

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

As of May 1, 2019, there were 6,331,147 shares of the issuer’s common stock, $0.001 par value per share, outstanding.

 

 

 

 

 

 

EXPLANATORY NOTE

 

This Amendment No. 1 on Form 10-Q/A to the Semler Scientific, Inc. (the “Company”) Quarterly Report on Form 10-Q, as originally filed with the Securities and Exchange Commission on May 3, 2019 (the “Original Filing”), is being filed solely to correct transposition errors in Note 5 Concentration of Credit Risk of the Notes to Condensed Consolidated Financial Statements included within Item 1. The revenues and accounts receivables percentages for the Company’s largest customers for the three months ended March 31, 2019 were inadvertently transposed in the Original Filing.

 

Except as described above, no other changes have been made to the Original Filing and this Form 10-Q/A does not does reflect subsequent events that may have occurred since the date of the Original Filing or amend, update or change the financial statements or any other items or disclosures in the Original Filing.

 

In accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended, we have included new certifications from our Principal Executive Officer and Principal Financial Officer dated the date of this Form 10-Q/A.

 

 

 

 

TABLE OF CONTENTS

 

      Page
Part I.   Financial Information 1
       
Item 1.   Financial Statements 1
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations 11
Item 3.   Quantitative and Qualitative Disclosures about Market Risk 13
Item 4.   Controls and Procedures 13
       
Part II.   Other Information 14
       
Item 1.   Legal Proceedings 14
Item 1A.   Risk Factors 14
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds 14
Item 3.   Defaults upon Senior Securities 14
Item 4.   Mine Safety Disclosures 14
Item 5.   Other Information 14
Item 6.   Exhibits 14
       
Signatures     15

 

 i 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This quarterly report on Form 10-Q contains forward-looking statements. Such forward-looking statements include those that express plans, anticipation, intent, contingency, goals, targets or future development and/or otherwise are not statements of historical fact. These forward-looking statements are based on our current expectations and projections about future events and they are subject to risks and uncertainties known and unknown that could cause actual results and developments to differ materially from those expressed or implied in such statements.

 

In some cases, you can identify forward-looking statements by terminology, such as “expects,” “anticipates,” “intends,” “estimates,” “plans,” “believes,” “seeks,” “may,” “should,” “continue,” “could” or the negative of such terms or other similar expressions. Accordingly, these statements involve estimates, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them. Any forward-looking statements are qualified in their entirety by reference to the factors discussed throughout this report.

 

You should read this quarterly report and the documents that we reference herein and therein and have filed as exhibits to this report, completely and with the understanding that our actual future results may be materially different from what we expect. You should assume that the information appearing in this quarterly report is accurate as of the date of this report only. Because the risk factors referred to above could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. These risks and uncertainties, along with others, are described above under the heading “Risk Factors” in our annual report on Form 10-K filed with the Securities and Exchange Commission, or SEC, on March 7, 2019. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We qualify all of the information presented in this quarterly report, and particularly our forward-looking statements, by these cautionary statements.

 

 ii 

 

 

PART I—FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

Semler Scientific, Inc.

Condensed Statements of Income

(In thousands of U.S. Dollars, except share and per share data)

 

   (Unaudited) 
  

For the three months ended
March 31

 
   2019   2018 
         
Revenues  $6,761   $4,463 
           
Operating expenses:          
Cost of revenues   896    704 
Engineering and product development   569    367 
Sales and marketing   2,070    1,705 
General and administrative   1,372    874 
Total operating expenses   4,907    3,650 
Income from operations   1,854    813 
           
Interest expense, net   -    (32)
Related party interest expense   -    (75)
Other expense   -    (107)
           
Net income  $1,854   $706 
           
Net income per share:          
Basic  $0.29   $0.12 
Diluted  $0.23   $0.10 
           
Weighted average number of shares used in computing basic and diluted income per share:          
Basic   6,326,149    5,924,701 
Diluted   8,170,287    7,280,492 

 

See accompanying notes to unaudited condensed financial statements.

 

 1 

 

 

Semler Scientific, Inc.

Condensed Balance Sheets

(In thousands of U.S. Dollars, except share and per share data)

 

  

(Unaudited)

March 31,

   December 31, 
   2019   2018 
         
Assets          
           
Current Assets:          
Cash  $4,544   $3,284 
Trade accounts receivable, net of allowance for doubtful accounts of $52 and $52, respectively   2,533    2,801 
Prepaid expenses and other current assets   225    153 
Total current assets   7,302    6,238 
           
Assets for lease, net   1,518    1,243 
Property and equipment, net   220    223 
Long-term deposits   15    15 
Total assets  $9,055   $7,719 
           
Liabilities and Stockholders' Equity          
           
Current liabilities:          
Accounts payable  $257   $280 
Accrued expenses   1,806    2,797 
Deferred revenue   821    435 
Total current liabilities   2,884    3,512 
           
Long-term liabilities:          
           
Deferred rent   10    11 
Total long-term liabilities   10    11 
           
Stockholders' equity:          
Common stock, $0.001 par value; 50,000,000 shares authorized; 6,356,147 and 6,349,985 shares issued, and 6,331,147 and 6,324,985 outstanding (treasury shares of 25,000 and 25,000), respectively   6    6 
Additional paid-in capital   25,719    25,608 
Accumulated deficit   (19,564)   (21,418)
           
Total stockholders' equity   6,161    4,196 
           
Total liabilities and stockholders' equity  $9,055   $7,719 

 

See accompanying notes to unaudited condensed financial statements.

 

 2 

 

 

Semler Scientific, Inc.
Statements of Stockholders' Equity (Deficit)
 (In thousands of U.S. Dollars, except share and per share data)

 

For the Quarter Ended March 31, 2018

 

   Common Stock   Treasury Stock             
   Shares
Issued		   Common
Stock
Amount		   Shares   Amount   Additional
Paid-In
Capital		   Accumulated
Deficit		   Total
Stockholder's
Equity (Deficit)		 
Balance at December 31, 2017   5,902,244   $6    (25,000)  $-   $23,844   $(26,432)  $(2,582)
                                    
Warrant Exercises   32,975    -    -    -    64    -    64 
                                    
Stock Option Exercises   34,615    -    -    -    95    -    95 
                                    
Stock Compensation Expense   -    -    -    -    193    -    193 
                                    
Net income   -    -    -    -    -    706    706 
                                    
Balance at March 31, 2018   5,969,834   $6    (25,000)  $-   $24,196   $(25,726)  $(1,524)

 

For the Quarter Ended March 31, 2019

 

   Common Stock   Treasury Stock             
   Shares
Issued		   Common
Stock
Amount		   Shares   Amount   Additional
Paid-In
Capital		   Accumulated
Deficit		   Total
Stockholder's
Equity		 
Balance at December 31, 2018   6,349,985   $6    (25,000)  $-   $25,608   $(21,418)  $4,196 
                                    
Stock Option Exercises   6,162    -    -    -    13    -    13 
                                    
Stock-based Compensation   -    -    -    -    98    -    98 
                                    
Net income   -    -    -    -    -    1,854    1,854 
                                    
Balance at March 31, 2019   6,356,147   $6    (25,000)  $-   $25,719   $(19,564)  $6,161 

 

 3 

 

 

Semler Scientific, Inc.

Condensed Statements of Cash Flows

(In thousands of U.S. Dollars)

 

  

(Unaudited)

Three months ended March 31

 
   2019   2018 
     
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income  $1,854   $706 
           
Reconciliation of Net Income to Net Cash Provided by (Used in) Operating Activities:          
Amortization of debt discount   -    13 
Accretion of non-cash interest   -    65 
Depreciation   143    121 
Loss on disposal of assets for lease   34    69 
Bad debt expense   6    3 
Stock-based compensation expense   98    193 
Changes in Operating Assets and Liabilities:          
Trade accounts receivable   268    (1,064)
Prepaid expenses and other current assets   (72)   (93)
Accounts payable   (23)   (147)
Accrued expenses   (991)   (501)
Deferred revenue   386    269 
Net Cash Provided by (Used in) Operating Activities   1,703    (366)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Additions to property and equipment   (31)   (34)
Purchase of assets for lease, net    (425)   (58)
Net Cash Used in Investing Activities   (456)   (92)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Exercise of warrants   -    64 
Exercise of stock options   13    95 
Payments of loans payable   -    (739)
Net Cash Provided by (Used in) Financing Activities   13    (580)
           
INCREASE (DECREASE) IN CASH   1,260    (1,038)
CASH, BEGINNING OF PERIOD   3,284    1,457 
           
CASH, END OF PERIOD  $4,544   $419 
Cash paid for interest  $-   $142 

 

See accompanying notes to unaudited condensed financial statements

 

 4 

 

 

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

 

1.Basis of Presentation

 

Semler Scientific, Inc., a Delaware corporation (“Semler” or “the Company”), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2018 filed with the SEC on March 7, 2019 (the “Annual Report”). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.

 

Recently Issued Accounting Pronouncements

 

Accounting Pronouncements Recently Adopted

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“ASU No. 2014-09”). The amendment in this ASU provides guidance on the revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The core principle of this update provides guidance to identify the performance obligations under the contract(s) with a customer and how to allocate the transaction price to the performance obligations in the contract. It further provides guidance to recognize revenue when (or as) the entity satisfies a performance obligation. This standard will replace most existing revenue recognition guidance. On August 8, 2015, the FASB issued ASU 2015-14, which defers the effective date of ASU No. 2014-09 by one year, and permits early adoption as long as the adoption date is not before the original public entity effective date. Since the issuance of ASU 2014-09, the FASB has issued several amendments that clarify certain points, including ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Identifying Performance Obligations and Licensing, ASU 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 Emerging Issues Task Force Meeting, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients, and ASU No. 2016-20, Technical Corrections and Improvements to Topic 606. The updated revenue standard allows two methods of adoption: (1) retrospectively to each prior period presented (“full retrospective method”), or (2) retrospectively with the cumulative effect recognized in retained earnings as of the date of adoption (“modified retrospective method”). The new standard further requires new disclosures about contracts with customers, including the significant judgments the company has made when applying the guidance. The Company adopted the new standard effective January 1, 2019, using the modified retrospective transition method. The Company determined that the adoption of this new standard did not have a material impact on its financial statements.

 

Topic 606 affects revenue recognition for the Company’s variable license fee contracts, which represents approximately $1,500 and $750 of revenue for the quarters ended March 31, 2019 and 2018, respectively. Essentially all of the variable license fee contracts are with large healthcare organizations. The remainder of the revenue is earned from leasing the Company's testing product for a fixed monthly fee, which is not subject to Topic 606. It was determined that the impact of the new standard has no effect on the way revenue was currently being recognized. Reusable hardware equipment or accessories may be provided to a customer for a set price and then use of the associated software is billed to the customer monthly based on volume of use. Under this scenario, revenue is recognized when and only when the customer uses the product. The Company is rendering a service and recognizes revenue in direct proportion to how much service is rendered. The sale of the equipment or accessories is recognized as hardware sales upon shipment to the customer. The initial contract is for a specified time period with automatic renewal each period thereafter until canceled. In case there is a violation of any term of the contract, the Company may deactivate the service remotely, so that the customer cannot continue to use the product.

 

 5 

 

 

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

 

Accounting Pronouncements Not Yet Adopted

 

In January 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU No. 2016-02"). Under the new guidance in ASU No. 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged, however, certain targeted improvements were made. ASU No. 2016-02 also simplifies the accounting for sale and leaseback transactions. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The new standard also requires expanded disclosures regarding leasing arrangements. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements. This ASU provides another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date and recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. This ASU also provides further guidance on lessors accounting policy election to not separate non-lease components from the associated lease components and limits this to circumstances in which the non-lease component or components otherwise would be accounted for under the new revenue guidance and both (1) the timing and pattern of transfer are the same for the non-lease component(s) and associated lease component, and (2) the lease component, if accounted for separately, would be classified as a an operating lease. In December 2018, the FASB issued ASU No. 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors. This ASU provide narrow scope improvements for lessor accounting by permitting lessors, as an accounting policy election, to treat certain sales taxes and other similar taxes as lessee costs, to exclude lessor costs paid by lessees directly to third parties from variable payments, and clarify the accounting by lessors for variable payments that related to both a lease component and a nonlease component. In January 2019, the FASB issued ASU No. 2019-01, Leases Codification Improvements, which reinstates the exception for lessors that are not manufacturers or dealers for determining fair value of the leased property as the underlying asset’s cost, clarifies the presentation on the statement of cash flows for sales type and direct financing leases for lessors that are depository and lending institutions and clarifies the transition disclosures related to accounting changes and error corrections in the year of adoption of the ASU. This update is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This ASU requires timelier recording of credit losses on loans and other financial instruments held. Instead of reserves based on a current probability analysis, ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. All organizations will now use forward-looking information to better inform their credit loss estimates. ASU 2016-13 requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. These disclosures include qualitative and quantitative requirements that provide information about the amounts recorded in the financial statements. In addition, ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. This standard is effective for the Company’s fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the effect the new standard will have on its financial statements.

 

In June 2018, the FASB issued ASU No. 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of costs. The ASU specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. This standard is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.

 

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this ASU modify the disclosure requirements on fair value measurements removing the requirements to disclosure amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. In addition, it modified certain disclosures related to Level 3 fair value measurements and added additional disclosures regarding the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements and the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period. This update is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this update to have a material impact on its financial statements.

 

 6 

 

 

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

 

2.Assets for Lease, net

 

Assets for lease consist of the following:

 

   March 31,
2019		   December 31,
2018		 
         
Assets for lease  $2,568   $2,218 
Less: accumulated depreciation   (1,050)   (975)
Assets for lease, net  $1,518   $1,243 

 

Depreciation expense amounted to $109 and $87 for the three months ended March 31, 2019 and 2018, respectively. Reduction to accumulated depreciation for returned items was $35 and $33 for the three months ended March 31, 2019 and 2018, respectively. The Company recognized a loss on disposal of assets for lease in the amount of $34 and $69 for the three months ended March 31, 2019 and 2018, respectively.

 

3.Property and Equipment, net

 

Capital assets consist of the following:

 

   March 31,
2019		   December 31,
2018		 
         
Capital assets  $488   $457 
Less: accumulated depreciation   (268)   (234)
Capital assets, net  $220   $223 

 

Depreciation expense amounted to $34 and $24 for the three months ended March 31, 2019 and 2018, respectively.

 

4.Accrued Expenses

 

Accrued expenses consist of the following:

 

   March 31,
2019		   December 31,
2018		 
         
Compensation  $1,450   $2,442 
Miscellaneous accruals   356    355 
Total accrued expenses  $1,806   $2,797 

 

5.Concentration of Credit Risk

 

Credit risk is the risk of loss from amounts owed by the financial counterparties. Credit risk can occur at multiple levels; as a result of broad economic conditions, challenges within specific sectors of the economy, or from issues affecting individual companies. Financial instruments that potentially subject the Company to credit risk consist of cash and accounts receivable.

 

The Company maintains cash with major financial institutions. The Company’s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. The Company limits its credit risk by dealing with counterparties that are considered to be of high credit quality and by performing periodic evaluations of the relative credit standing of these financial institutions.

 

Management periodically monitors the creditworthiness of its customers and believes that it has adequately provided for any exposure to potential credit loss. For the three months ended March 31, 2018, two customers accounted for 58.2% and 11.9% of the Company’s revenue, respectively. For the three months ended March 31, 2019, two customers accounted for 55.6% and 12.5% of the Company’s revenue, respectively. As of December 31, 2018, two customers accounted for 43.5% and 40.4% of the Company’s accounts receivable, respectively. As of March 31, 2019, two customers accounted for 41.8% and 22.3% of the Company’s accounts receivable, respectively.  The Company’s largest customer in terms of both revenue and accounts receivable in the three months ended March 31, 2019 is a U.S. diversified healthcare company and its affiliated plans.

 

 7 

 

 

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

 

As of December 31, 2018, two vendors accounted for 11.0% and 10.8% of the Company’s accounts payable, respectively. As of March 31, 2019, three vendors accounted for 23.3%, 20.3%, and 11.1% of the Company’s accounts payable, respectively.

 

6.Commitments and Contingencies

 

Facilities Leases

 

The Company recognized facilities lease expenses of $17 and $17 for the three months ended March 31, 2019 and 2018, respectively.

 

Indemnification Obligations

 

The Company enters into agreements with customers, partners, lenders, consultants, lessors, contractors, sales representatives and parties to certain transactions in the ordinary course of the Company’s business. These agreements may require the Company to indemnify the other party against third party claims alleging that its product infringes a patent or copyright. Certain of these agreements require the Company to indemnify the other party against losses arising from: a breach of representations or covenants, claims relating to property damage, personal injury or acts or omissions of the Company, its employees, agents or representatives. The Company has also agreed to indemnify the directors and certain of the officers and employees in accordance with the by-laws of the Company. These indemnification provisions will vary based upon the nature and terms of the agreements. In many cases, these indemnification provisions do not contain limits on the Company’s liability, and the occurrence of contingent events that will trigger payment under these indemnities is difficult to predict. As a result, the Company cannot estimate its potential liability under these indemnities. The Company believes that the likelihood of conditions arising that would trigger these indemnities is remote and, historically, the Company had not made any significant payment under such indemnification provisions. Accordingly, the Company has not recorded any liabilities relating to these agreements. In certain cases, the Company has recourse against third parties with respect to the aforesaid indemnities, and the Company believes it maintains adequate levels of insurance coverage to protect the Company with respect to potential claims arising from such agreements.

 

7.Stock Option Plan

 

The Company’s stock-based compensation program is designed to attract and retain employees while also aligning employees' interests with the interests of its stockholders. Stock options have been granted to employees under the stockholder-approved 2007 Key Person Stock Option Plan (“2007 Plan”) or the stockholder-approved 2014 Stock Incentive Plan (“2014 Plan”). Stockholder approval of the 2014 Plan became effective in September 2014. The 2014 Plan originally provided that the aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2014 Plan may not exceed 450,000 shares (the “Share Reserve”), however in October 2015, the stockholders approved a 1,500,000 increase to the Share Reserve. In addition, the Share Reserve automatically increases on January 1st of each year, for a period of not more than 10 years, beginning on January 1st of the year following the year in which the 2014 Plan became effective and ending on (and including) January 1, 2024, in an amount equal to 4% of the total number of shares of common stock outstanding on December 31st of the preceding calendar year. The Company’s Board of Directors may act prior to January 1st of a given year to provide that there will be no January 1st increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser number of shares of common stock than would otherwise occur. On January 1, 2015, the Share Reserve increased by 188,640 shares due to the automatic 4% increase. On January 1, 2016, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2017, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2018, the Share Reserve increased by 235,090 shares due to the automatic 4% increase. The Share Reserve is currently 2,783,616 shares as of March 31, 2019.

 

In light of stockholder approval of the 2014 Plan, the Company no longer grants equity awards under the 2007 Plan. As of March 31, 2019, 0 shares of an aggregate total of 407,500 shares were available for future stock-based compensation grants under the 2007 Plan and 987,337 shares of an aggregate total of 2,783,616 shares were available for future stock-based compensation grants under the 2014 Plan.

 

 8 

 

 

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

 

Aggregate intrinsic value represents the difference between the closing market value as of March 31, 2019 of the underlying common stock and the exercise price of outstanding, in-the-money options. A summary of the Company’s stock option activity and related information for the three months ended March 31, 2019 is as follows:

 

   Options Outstanding 
   Number of
Stock Options
Outstanding		   Weighted
Average
Exercise Price		   Weighted
Average
Remaining
Contractual
Term (In Years)		   Aggregate
Intrinsic Value
 (in thousands)		 
Balance, January 1, 2019   1,761,447   $3.18    6.84   $55,000 
Options exercised   (6,162)   2.10           
Balance, March 31, 2019   1,755,285   $3.18    6.59   $69,492 
Exercisable as of March 31, 2019   1,554,102   $2.99    6.41   $61,827 

 

The total compensation cost related to unvested stock option awards not yet recognized was $693 as of March 31, 2019. The weighted average period over which the total unrecognized compensation cost related to these unvested stock awards will be recognized is 1.33 years. The weighted average fair value of options granted during the three months ended March 31, 2018 was $5.97 per share, or an aggregate grant date fair value of $806. There were no options granted during the three months ended March 31, 2019.

 

On January 2, 2018 the Compensation Committee of the Company’s Board of Directors granted, and the full Board ratified, an option to acquire an aggregate of 125,000 shares under the 2014 Plan to the Company’s CEO. This option vests 25% on the one-year anniversary of the grant date and monthly thereafter for 36 months, such that the option is vested in full on the four-year anniversary of the grant date. On January 2, 2018 the Company’s Compensation Committee granted, and the full Board ratified, options to each of the then-seated non-employee Directors to acquire 5,000 shares, for an aggregate of 10,000 shares, under the 2014 Plan. These options vest on the one-year anniversary of their grant date. On February 28, 2018 the Compensation Committee of the Company’s Board of Directors accelerated the vesting on stock options issued to consultants such that all unvested shares were vested on that date. This resulted in a one-time expense of $49 during the three months ended March 31, 2018.

 

Determining the Fair Value of Stock Options

 

The Company uses the Black-Scholes pricing model to determine the fair value of stock options. The fair value of each option grant is estimated on the date of the grant. There were no stock options granted during the three months ended March 31, 2019. There were 135,000 stock options granted during the three months ended March 31, 2018. The following assumptions for the periods presented were:

 

   Three months ended March 31, 
   2019   2018 
         
Expected term (in years)   -   5 
Risk-free interest rate   -%   2.2%
Expected volatility   -%   0.99%
Expected dividend rate   -%   -%

 

The assumptions are based on the following for each of the periods presented:

 

Valuation Method — The Company estimates the fair value of its stock options using the Black-Scholes option pricing model.

 

Expected Term — The Company estimates the expected term consistent with the simplified method identified by the SEC. The Company elected to use the simplified method because of its limited history of stock option exercise activity and its stock options meet the criteria of the “plain-vanilla” options as defined by the SEC. The simplified method calculates the expected term as the average of the vesting and contractual terms of the award.

 

Volatility — The Company derives this number from the historical stock volatilities of the Company’s stock over a period approximately equal to the expected term of the options.

 

 9 

 

 

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

 

 

Risk-free Interest Rate — The risk-free interest rate is based on median U.S. Treasury zero coupon issues with remaining terms similar to the expected term on the options.

 

Expected Dividend — The Company has never declared or paid any cash dividends and does not plan to pay cash dividends in the foreseeable future, and therefore, used an expected dividend yield of zero in the valuation model.

 

Forfeiture — Beginning in the first quarter of 2017, the Company implemented ASU 2016-09, and elected to true-up calculations at the time of forfeiture, rather than creating an estimate at the time of option issuance.

 

The Company has recorded an expense of $98 and $193 as it relates to stock-based compensation for the three months ended March 31, 2019 and 2018, respectively:

 

   Three months ended March 31, 
   2019   2018 
Cost of Revenue  $1   $1 
Engineering and Product Development   7    8 
Sales and Marketing   15    29 
General and Administrative   75    155 
Total  $98   $193 

 

 

8.Net Income Per Share, Basic and Diluted

 

Basic earnings per share (“EPS”) represent net income attributable to common stockholders divided by the weighted average number of common shares outstanding during the measurement period. Diluted EPS represents net income attributable to common stockholders divided by the weighted average number of common shares outstanding during the measurement period while also giving effect to all potentially dilutive common shares that were outstanding during the period using the treasury stock method.

 

Basic and diluted net EPS is calculated as follows:

 

   Three months ended March 31, 
   2019   2018 
   Shares   Net Income   EPS   Shares   Net Income   EPS 
Basic EPS   6,326,149   $1,854   $0.29    5,924,701   $706   $0.12 
Common stock warrants   246,843    -         225,154    -      
Common stock options   1,597,295    -         1,130,637    -      
Diluted EPS   8,170,287   $1,854   $0.23    7,280,492   $706   $0.10 

 

The following weighted average shares outstanding of common stock equivalents were excluded from the computation of diluted net loss per share for the three months ended March 31, 2019 and 2018 because including them would have been anti-dilutive:

 

   Three months ended
March 31,		 
   2019   2018 
Weighted average shares outstanding:        
Common stock warrants   -    71,500 
Options   -    135,000 
Total   -    206,500 

 

 10 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion and analysis should be read together with our condensed unaudited financial statements and the related notes appearing elsewhere in this quarterly report on Form 10-Q and with the audited financial statements and notes for the fiscal year ended December 31, 2018, and the information under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K filed with the SEC on March 7, 2019, or the Annual Report. This discussion contains forward-looking statements reflecting our current expectations that involve risks and uncertainties. See “Cautionary Note Regarding Forward-Looking Statements” for a discussion of the uncertainties, risks and assumptions associated with these statements. Actual results and the timing of events could differ materially from those discussed in our forward-looking statements as a result of many factors, including those set forth under “Risk Factors” in our Annual Report.

 

Overview

 

We are an emerging growth company providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Our mission is to develop, manufacture and market innovative proprietary products and services that assist our customers in evaluating and treating chronic diseases. In 2011, we began commercializing our first patented and U.S. Food and Drug Administration, or FDA, cleared product, which measured arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease, or PAD. In March 2015, we received FDA 510(k) clearance for the next generation version of our product, QuantaFlo™, which we began commercializing in August 2015. We believe our products and services position us to provide valuable information to our customer base, which in turn permits them to better guide patient care.

 

In the three months ended March 31, 2019, we had total revenues of $6,761,000 and net income of $1,854,000 compared to total revenues of $4,463,000 and net income of $706,000 in the same period in 2018.

 

Emerging Growth Company Elections

 

The JOBS Act provides that an emerging growth company, such as our company, can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of these accounting standards until they would otherwise apply to private companies. We have elected to avail ourselves of this exemption. As a result, our financial statements may not be comparable to other public companies that comply with public company effective dates. In the future, we may elect to opt out of the extended period for adopting new accounting standards. If we do so, we would need to disclose such decision and it would be irrevocable. We expect to cease being an emerging growth company as of December 31, 2019, the last day of the fiscal year following the fifth anniversary of our initial public offering.

 

Factors Affecting Future Results

 

We have not identified any factors that have a recurring effect that are necessary to understand period to period comparisons as appropriate, nor any one-time events that have an effect on the financials.

 

Results of Operations

 

Three Months Ended March 31, 2019 Compared to Three Months Ended March 31, 2018

 

Revenues

 

We had revenues of $6,761,000 for the three months ended March 31, 2019, an increase of $2,298,000, or 51%, compared to $4,463,000 in the same period in 2018. Our revenues are primarily from fees charged to customers for use of our vascular testing products and from sale of accessories used with these products. We recognized revenues of $6,515,000 from fees for our vascular testing products for the quarter ended March 31, 2019, an increase of $2,157,000 compared to $4,358,000 in the same period of the prior year. The remainder was from other items, such as the sale of equipment, supplies or accessories sales, which were $246,000 in the three months ended March 31, 2019, as compared to $105,000 in the same period of the prior year.

 

Revenues from fees for vascular testing products are recognized monthly for each unit installed with a customer, usually billed as a fixed monthly fee or as a variable monthly fee dependent on usage. The primary reason for the increase in revenues was growth in the number of installed units from both new customers and established customers, which we believe is the result of our sales and marketing efforts.

 

 11 

 

 

Operating expenses

 

We had total operating expenses of $4,907,000 for the three months ended March 31, 2019, an increase of $1,257,000, or 34%, compared to $3,650,000 in the same period in the prior year. The primary reason for this change was overall growth in our business, which led to increased compensation of the sales team, as well as an increase in our field sales and technical support personnel headcount to service the expanding number of customers. The changes in the various components of our operating expenses are described below.

 

Cost of revenues

 

We had cost of revenues of $896,000 for the three months ended March 31, 2019, an increase of $192,000, or 27%, compared to $704,000 in the same period of the prior year. The primary reason for this change was increased costs due to increased sales volume of, placement of and technical support for installations in the field. These increases were partially offset by lower depreciation per unit per month as a greater percentage of installations were software and sensor only rather than laptop, software and sensor, as well as lower residual value for retired units. As a percentage of revenues, cost of revenues decreased to 13%, as compared to 16%, primarily due to revenue growing at a faster pace than cost of revenue.

 

Engineering and product development expense

 

We had engineering and product development expense of $569,000 for the three months ended March 31, 2019, an increase of $202,000, or 55%, compared to $367,000 in the same period of the prior year. The increase was primarily due to timing of consultant costs, personnel and other costs associated with our product development and customization efforts.

 

Sales and marketing expense

 

We had sales and marketing expense of $2,070,000 for the three months ended March 31, 2019, an increase of $365,000, or 21%, compared to $1,705,000 in the same period of the prior year. The increase was primarily due to higher sales compensation and personnel expense, as well as increased headcount and expense, each associated with a growing business.

 

General and administrative expense

 

We had general and administrative expense of $1,372,000 for the three months ended March 31, 2019, an increase of $498,000, or 57%, compared to $874,000 in the same period of the prior year. The increase was primarily due to the growth in our business, which led to increased expenses to support a growing company, including higher infrastructure costs, insurance and other professional fees, as well as higher compensation and personnel expense.

 

Other expense

 

We had no other expense for the three months ended March 31, 2019, a decrease of $107,000, or 100%, compared to $107,000 in the same period of the prior year. The decrease was primarily due to a decrease in interest expense of $106,000 associated with retirement of notes payable, partially offset by other expense of $1,000.

 

Net income

 

For the foregoing reasons, we had net income of $1,854,000, or $0.29 per basic share and $0.23 per diluted share, for the three months ended March 31, 2019, an increase of $1,148,000, or 163%, compared to a net income of $706,000, or $0.12 per basic share and $0.10 per diluted share, for the same period of the prior year.

 

Liquidity and Capital Resources

 

We had cash of $4,544,000 at March 31, 2019 compared to $3,284,000 at December 31, 2018, and total current liabilities of $2,884,000 at March 31, 2019 compared to $3,512,000 at December 31, 2018. As of March 31, 2019 we had working capital of approximately $4,418,000.

 

Operating activities

 

We generated $1,703,000 of net cash from operating activities for the three months ended March 31, 2019 compared to using $366,000 of net cash in operating activities for the same period of the prior year. The improvement was primarily due to changes in net income, as well as both non-cash adjustments and operating assets and liabilities, which occurred due to growth in our business and affected depreciation, accrued compensation, accrued expenses, accounts payable, deferred revenue and trade accounts receivable.

 

 12 

 

 

Investing activities

 

We used $456,000 of net cash in investing activities for the three months ended March 31, 2019, which reflects purchases of assets for lease of $425,000 and fixed asset purchases of $31,000 to support our growing business.

 

We used $92,000 of net cash in investing activities for the three months ended March 31, 2018, which reflects purchases of assets for lease of $58,000 and fixed asset purchases of $34,000 to support our growing business.

 

Financing activities

 

We generated $13,000 in net cash in financing activities during the three months ended March 31, 2019, primarily due to proceeds from exercise of stock options.

 

We used $580,000 in net cash in financing activities during the three months ended March 31, 2018, reflecting the payment of loans payable of $739,000, partially offset by proceeds from exercise of warrants and stock options of $159,000.

 

Off-Balance Sheet Arrangements

 

As of each of March 31, 2019 and December 31, 2018, we had no off-balance sheet arrangements.

 

Commitments and Contingencies

 

As of each of March 31, 2019 and December 31, 2018, other than employment/consulting agreements with key executive officers and our facilities lease obligation, we had no material commitments other than the liabilities reflected in our financial statements.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Not applicable.

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

In evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our management, with the participation of our chief executive officer, our senior vice president, finance and accounting and our vice president, finance, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this quarterly report on Form 10-Q. Based on that evaluation, our chief executive officer, our senior vice president, finance and accounting, and our vice president, finance concluded that our disclosure controls and procedures were not effective, at the reasonable assurance level, as of the end of the period covered by this report to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934 (1) is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) is accumulated and communicated to management, including our chief executive officer, senior vice president, finance and accounting, and our vice president, finance as appropriate to allow timely decisions regarding required disclosure, due to the existence of material weaknesses in our internal control over financial reporting

 

Changes in Internal Control over Financial Reporting

 

In an effort to remediate our prior material weaknesses, in the first quarter of 2019, we implemented additional controls to properly account for payroll taxes associated with employee stock option exercises. Other than these remedial changes, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during our first fiscal quarter ended March 31, 2019.

 

 13 

 

 

PART II—OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

Not applicable.

 

Item 1A. Risk Factors.

 

Not applicable.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

Not applicable.

 

Item 6. Exhibits.

 

Exh. No.   Exhibit Name
31.1   Rule 13a-14(a) Certification of Principal Executive Officer of Registrant
31.2   Rule 13a-14(a) Certification of Principal Financial Officer of Registrant
32.1   Section 1350 Certification
     
101.INS   XBRL Instance Document
101.SCH   XBRL Taxonomy Extension Schema
101.CAL   XBRL Taxonomy Extension Calculation Linkbase
101.DEF   XBRL Taxonomy Extension Definition Linkbase
101.LAB   XBRL Taxonomy Extension Label Linkbase
101.PRE   XBRL Taxonomy Extension Presentation Linkbase

 

 14 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

May 7, 2019  SEMLER SCIENTIFIC, INC.
   
  By: /s/ Douglas Murphy-Chutorian, M.D.
    Douglas Murphy-Chutorian, M.D.
    Chief Executive Officer
     
  By: /s/ Andrew B. Weinstein
    Andrew B. Weinstein
    Senior Vice President, Finance and Accounting

 

 15 

 EX-31.1 2 tv520855_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATIONS

 

I, Douglas Murphy-Chutorian, M.D., certify that:

 

1.          I have reviewed this quarterly report on Form 10-Q/A of Semler Scientific, Inc., a Delaware corporation;

 

2.          Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.          Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.          The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.          The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Dated: May 7, 2019   
  /s/ Douglas Murphy-Chutorian, M.D.
  Douglas Murphy-Chutorian, M.D.
 

Chief Executive Officer

(Principal Executive Officer)

 

 

 EX-31.2 3 tv520855_ex31-2.htm EXHIBIT 31.2

 

Exhibit 31.2

 

I, Andrew B. Weinstein, certify that:

 

1.           I have reviewed this quarterly report on Form 10-Q/A of Semler Scientific, Inc., a Delaware corporation;

 

2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.           The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.           The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Dated: May 7, 2019   
   
  /s/ Andrew B. Weinstein
  Andrew B. Weinstein
Senior Vice President, Finance and Accounting
  (Principal Financial Officer)

 

 

 

 EX-32.1 4 tv520855_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

SECTION 1350 CERTIFICATION

 

Each of the undersigned, Douglas Murphy-Chutorian, M.D., Chief Executive Officer of Semler Scientific, Inc., a Delaware corporation (the “Company”), and Andrew B. Weinstein, Senior Vice President, Finance and Accounting of the Company, does hereby certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge (1) the quarterly report on Form 10-Q/A of the Company for the period ended March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

  /s/ Douglas Murphy-Chutorian, M.D.
  Name: Douglas Murphy-Chutorian, M.D.
  Title: Chief Executive Officer
  (Principal Executive Officer)
  Dated: May 7, 2019 
   
  /s/ Andrew B. Weinstein
  Name: Andrew B. Weinstein
  Title: Senior Vice President, Finance and Accounting
  (Principal Financial Officer)
  Dated: May 7, 2019 

 

This certification accompanies and is being “furnished” with this Report, shall not be deemed “filed” by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing. A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

 EX-101.INS 5 smlr-20190331.xml XBRL INSTANCE DOCUMENT 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember 2015-01-01 2015-01-31 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember 2015-10-01 2015-10-31 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember 2016-01-01 2016-01-31 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember 2017-01-01 2017-01-31 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember smlr:NonEmployeeDirectorsMember 2018-01-02 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember us-gaap:ChiefExecutiveOfficerMember 2018-01-02 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember smlr:NonEmployeeDirectorsMember 2018-01-01 2018-01-02 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember us-gaap:ChiefExecutiveOfficerMember 2018-01-01 2018-01-02 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember 2018-01-01 2018-01-31 0001554859 2018-01-01 2018-03-31 0001554859 us-gaap:CostOfSalesMember 2018-01-01 2018-03-31 0001554859 smlr:EngineeringAndProductDevelopmentMember 2018-01-01 2018-03-31 0001554859 us-gaap:SellingAndMarketingExpenseMember 2018-01-01 2018-03-31 0001554859 us-gaap:GeneralAndAdministrativeExpenseMember 2018-01-01 2018-03-31 0001554859 us-gaap:WarrantMember 2018-01-01 2018-03-31 0001554859 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-03-31 0001554859 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-03-31 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-03-31 0001554859 smlr:CustomerTwoConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-03-31 0001554859 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001554859 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001554859 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001554859 2018-03-31 0001554859 2018-12-31 0001554859 2019-01-01 2019-03-31 0001554859 us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0001554859 smlr:EngineeringAndProductDevelopmentMember 2019-01-01 2019-03-31 0001554859 us-gaap:SellingAndMarketingExpenseMember 2019-01-01 2019-03-31 0001554859 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-03-31 0001554859 us-gaap:WarrantMember 2019-01-01 2019-03-31 0001554859 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-03-31 0001554859 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2019-01-01 2019-03-31 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2019-01-01 2019-03-31 0001554859 smlr:CustomerTwoConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2019-01-01 2019-03-31 0001554859 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2019-01-01 2019-03-31 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2019-01-01 2019-03-31 0001554859 smlr:CustomerTwoConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2019-01-01 2019-03-31 0001554859 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001554859 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001554859 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001554859 2019-03-31 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember 2019-03-31 0001554859 2019-05-01 0001554859 2017-12-31 0001554859 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001554859 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001554859 us-gaap:RetainedEarningsMember 2017-12-31 0001554859 us-gaap:RetainedEarningsMember 2018-03-31 0001554859 us-gaap:CommonStockMember 2017-12-31 0001554859 us-gaap:CommonStockMember 2018-03-31 0001554859 us-gaap:TreasuryStockMember 2017-12-31 0001554859 us-gaap:TreasuryStockMember 2018-03-31 0001554859 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001554859 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001554859 us-gaap:RetainedEarningsMember 2018-12-31 0001554859 us-gaap:RetainedEarningsMember 2019-03-31 0001554859 us-gaap:CommonStockMember 2018-12-31 0001554859 us-gaap:CommonStockMember 2019-03-31 0001554859 us-gaap:TreasuryStockMember 2018-12-31 0001554859 us-gaap:TreasuryStockMember 2019-03-31 xbrli:shares iso4217:USD iso4217:USDxbrli:shares smlr:Customer xbrli:pure Semler Scientific, Inc. 0001554859 smlr --12-31 Non-accelerated Filer 6331147 10-Q/A 2019-03-31 true 2019 Q1 true true false 4463000 6761000 704000 896000 367000 569000 1705000 2070000 874000 1372000 3650000 4907000 813000 1854000 32000 75000 107000 706000 706000 1854000 1854000 0.12 0.29 0.10 0.23 5924701 6326149 7280492 8170287 419000 3284000 4544000 1457000 2801000 2533000 153000 225000 6238000 7302000 1243000 1518000 223000 220000 15000 15000 7719000 9055000 280000 257000 2797000 1806000 435000 821000 3512000 2884000 11000 10000 11000 10000 6000 6000 25608000 25719000 -21418000 -19564000 -1524000 4196000 6161000 -2582000 23844000 24196000 -26432000 -25726000 6000 6000 25608000 25719000 -21418000 -19564000 6000 6000 7719000 9055000 52000 52000 0.001 0.001 50000000 50000000 6349985 6356147 6324985 6331147 25000 25000 13000 65000 121000 143000 -69000 -34000 3000 6000 193000 98000 1064000 -268000 93000 72000 -147000 -23000 -501000 -991000 269000 386000 -366000 1703000 34000 31000 58000 425000 -92000 -456000 64000 95000 13000 739000 -580000 13000 -1038000 1260000 142000 <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"><b>1.</b></td> <td><b>Basis of Presentation</b></td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Semler Scientific, Inc., a Delaware corporation (&#8220;Semler&#8221; or &#8220;the Company&#8221;), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (&#8220;GAAP&#8221;) and applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company&#8217;s annual report on Form 10-K for the year ended December 31, 2018 filed with the SEC on March 7, 2019 (the &#8220;Annual Report&#8221;). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 9pt; margin: 0pt 0px 0pt 27pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>Recently Issued Accounting Pronouncements</b></p> <p style="widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Accounting Pronouncements Recently Adopted</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>&#160;</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) No. 2014-09, Revenue from Contracts with Customers (&#8220;ASU No. 2014-09&#8221;). The amendment in this ASU provides guidance on the revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The core principle of this update provides guidance to identify the performance obligations under the contract(s) with a customer and how to allocate the transaction price to the performance obligations in the contract. It further provides guidance to recognize revenue when (or as) the entity satisfies a performance obligation. This standard will replace most existing revenue recognition guidance. On August 8, 2015, the FASB issued ASU 2015-14, which defers the effective date of ASU No. 2014-09 by one year, and permits early adoption as long as the adoption date is not before the original public entity effective date. Since the issuance of ASU 2014-09, the FASB has issued several amendments that clarify certain points, including ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Identifying Performance Obligations and Licensing, ASU 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 Emerging Issues Task Force Meeting, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients, and ASU No. 2016-20, Technical Corrections and Improvements to Topic 606. The updated revenue standard allows two methods of adoption: (1) retrospectively to each prior period presented (&#8220;full retrospective method&#8221;), or (2) retrospectively with the cumulative effect recognized in retained earnings as of the date of adoption (&#8220;modified retrospective method&#8221;). The new standard further requires new disclosures about contracts with customers, including the significant judgments the company has made when applying the guidance. The Company adopted the new standard effective January 1, 2019, using the modified retrospective transition method. The Company determined that the adoption of this new standard did not have a material impact on its financial statements.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Topic 606 affects revenue recognition for the Company&#8217;s variable license fee contracts, which represents approximately $1,500 and $750 of revenue for the quarters ended March 31, 2019 and 2018, respectively. Essentially all of the variable license fee contracts are with large healthcare organizations. The remainder of the revenue is earned from leasing the Company's testing product for a fixed monthly fee, which is not subject to Topic 606. It was determined that the impact of the new standard has no effect on the way revenue was currently being recognized. Reusable hardware equipment or accessories may be provided to a customer for a set price and then use of the associated software is billed to the customer monthly based on volume of use. Under this scenario, revenue is recognized when and only when the customer uses the product. The Company is rendering a service and recognizes revenue in direct proportion to how much service is rendered. The sale of the equipment or accessories is recognized as hardware sales upon shipment to the customer. The initial contract is for a specified time period with automatic renewal each period thereafter until canceled. In case there is a violation of any term of the contract, the Company may deactivate the service remotely, so that the customer cannot continue to use the product.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Accounting Pronouncements Not Yet Adopted</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In January 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU No. 2016-02"). Under the new guidance in ASU No. 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee&#8217;s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee&#8217;s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged, however, certain targeted improvements were made. ASU No. 2016-02 also simplifies the accounting for sale and leaseback transactions. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The new standard also requires expanded disclosures regarding leasing arrangements. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements. This ASU provides another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date and recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. This ASU also provides further guidance on lessors accounting policy election to not separate non-lease components from the associated lease components and limits this to circumstances in which the non-lease component or components otherwise would be accounted for under the new revenue guidance and both (1) the timing and pattern of transfer are the same for the non-lease component(s) and associated lease component, and (2) the lease component, if accounted for separately, would be classified as a an operating lease. In December 2018, the FASB issued ASU No. 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors. This ASU provide narrow scope improvements for lessor accounting by permitting lessors, as an accounting policy election, to treat certain sales taxes and other similar taxes as lessee costs, to exclude lessor costs paid by lessees directly to third parties from variable payments, and clarify the accounting by lessors for variable payments that related to both a lease component and a nonlease component. In January 2019, the FASB issued ASU No. 2019-01, Leases Codification Improvements, which reinstates the exception for lessors that are not manufacturers or dealers for determining fair value of the leased property as the underlying asset&#8217;s cost, clarifies the presentation on the statement of cash flows for sales type and direct financing leases for lessors that are depository and lending institutions and clarifies the transition disclosures related to accounting changes and error corrections in the year of adoption of the ASU. This update is effective for the Company&#8217;s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (&#8220;ASU 2016-13&#8221;). This ASU requires timelier recording of credit losses on loans and other financial instruments held. Instead of reserves based on a current probability analysis, ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. All organizations will now use forward-looking information to better inform their credit loss estimates. ASU 2016-13 requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization&#8217;s portfolio. These disclosures include qualitative and quantitative requirements that provide information about the amounts recorded in the financial statements. In addition, ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. This standard is effective for the Company&#8217;s fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the effect the new standard will have on its financial statements.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In June 2018, the FASB issued ASU No. 2018-07, Compensation&#8212;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (&#8220;ASU 2018-07&#8221;). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of costs. The ASU specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor&#8217;s own operations by issuing share-based payment awards. This standard is effective for the Company&#8217;s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework&#8212;Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this ASU modify the disclosure requirements on fair value measurements removing the requirements to disclosure amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. In addition, it modified certain disclosures related to Level 3 fair value measurements and added additional disclosures regarding the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements and the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period. This update is effective for the Company&#8217;s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this update to have a material impact on its financial statements.</p> <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0pt;"></td> <td style="width: 0.5in;"><b>2.</b></td> <td><b>Assets for Lease, net</b></td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27.35pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>&#160;</b></p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Assets for lease consist of the following:</p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 80%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">March 31,&#160;<br />2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,&#160;<br />2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 985px;">Assets for lease</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 133px;">2,568</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 133px;">2,218</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Less: accumulated depreciation</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(1,050</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(975</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2.5pt;">Assets for lease, net</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">1,518</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">1,243</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27.35pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Depreciation expense amounted to $109 and $87 for the three months ended March 31, 2019 and 2018, respectively. Reduction to accumulated depreciation for returned items was $35 and $33 for the three months ended March 31, 2019 and 2018, respectively. The Company recognized a loss on disposal of assets for lease in the amount of $34 and $69 for the three months ended March 31, 2019 and 2018, respectively.</p> <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"><b>3.</b></td> <td><b>Property and Equipment, net</b></td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Capital assets consist of the following:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27.35pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 85%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">March 31,&#160;<br />2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,&#160;<br />2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 985px;">Capital assets</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 133px;">488</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 133px;">457</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Less: accumulated depreciation</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(268</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(234</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2.5pt;">Capital assets, net</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">220</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">223</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27.35pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Depreciation expense amounted to $34 and $24 for the three months ended March 31, 2019 and 2018, respectively.</p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0pt;"></td> <td style="width: 0.5in;"><b>4.</b></td> <td><b>Accrued Expenses</b></td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27.35pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Accrued expenses consist of the following:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 85%; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap" style="text-align: center;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">March 31,&#160;<br />2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2">December 31,&#160;<br />2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td nowrap="nowrap" style="text-align: right;" colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td nowrap="nowrap" style="text-align: right;" colspan="2">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="width: 985px;">Compensation</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 133px;">1,450</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 133px;">2,442</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Miscellaneous accruals</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">356</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">355</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2.5pt;">Total accrued expenses</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">1,806</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">2,797</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0pt;"></td> <td style="width: 0.5in;"><b>5.</b></td> <td><b>Concentration of Credit Risk</b></td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Credit risk is the risk of loss from amounts owed by the financial counterparties. Credit risk can occur at multiple levels; as a result of broad economic conditions, challenges within specific sectors of the economy, or from issues affecting individual companies. Financial instruments that potentially subject the Company to credit risk consist of cash and accounts receivable.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company maintains cash with major financial institutions. The Company&#8217;s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. The Company limits its credit risk by dealing with counterparties that are considered to be of high credit quality and by performing periodic evaluations of the relative credit standing of these financial institutions.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Management periodically monitors the creditworthiness of its customers and believes that it has adequately provided for any exposure to potential credit loss. For the three months ended March 31, 2018, two customers accounted for 58.2% and 11.9% of the Company&#8217;s revenue, respectively. For the three months ended March 31, 2019, two customers accounted for 55.6% and 12.5% of the Company&#8217;s revenue, respectively. As of December 31, 2018, two customers accounted for 43.5% and 40.4% of the Company&#8217;s accounts receivable, respectively. As of March 31, 2019, two customers accounted for 41.8% and 22.3% of the Company&#8217;s accounts receivable, respectively.<b>&#160;&#160;</b>The Company&#8217;s largest customer in terms of both revenue and accounts receivable in the three months ended March 31, 2019 is a U.S. diversified healthcare company and its affiliated plans.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"></p> <p style="text-align: center; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">As of December 31, 2018, two vendors accounted for 11.0% and 10.8% of the Company&#8217;s accounts payable, respectively. As of March 31, 2019, three vendors accounted for 23.3%, 20.3%, and 11.1% of the Company&#8217;s accounts payable, respectively.</p> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 0px;"></td> <td style="text-align: left; width: 0.5in;"><b>6.</b></td> <td style="text-align: justify;"><b>Commitments and Contingencies</b></td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>&#160;</b></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>Facilities Leases</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company recognized facilities lease expenses of $17 and $17 for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>Indemnification Obligations</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company enters into agreements with customers, partners, lenders, consultants, lessors, contractors, sales representatives and parties to certain transactions in the ordinary course of the Company&#8217;s business. These agreements may require the Company to indemnify the other party against third party claims alleging that its product infringes a patent or copyright. Certain of these agreements require the Company to indemnify the other party against losses arising from: a breach of representations or covenants, claims relating to property damage, personal injury or acts or omissions of the Company, its employees, agents or representatives. The Company has also agreed to indemnify the directors and certain of the officers and employees in accordance with the by-laws of the Company. These indemnification provisions will vary based upon the nature and terms of the agreements. In many cases, these indemnification provisions do not contain limits on the Company&#8217;s liability, and the occurrence of contingent events that will trigger payment under these indemnities is difficult to predict. As a result, the Company cannot estimate its potential liability under these indemnities. The Company believes that the likelihood of conditions arising that would trigger these indemnities is remote and, historically, the Company had not made any significant payment under such indemnification provisions. Accordingly, the Company has not recorded any liabilities relating to these agreements. In certain cases, the Company has recourse against third parties with respect to the aforesaid indemnities, and the Company believes it maintains adequate levels of insurance coverage to protect the Company with respect to potential claims arising from such agreements.</p> <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"><b>7.</b></td> <td><b>Stock Option Plan</b></td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company&#8217;s stock-based compensation program is designed to attract and retain employees while also aligning employees' interests with the interests of its stockholders. Stock options have been granted to employees under the stockholder-approved 2007 Key Person Stock Option Plan (&#8220;2007 Plan&#8221;) or the stockholder-approved 2014 Stock Incentive Plan (&#8220;2014 Plan&#8221;). Stockholder approval of the 2014 Plan became effective in September 2014. The 2014 Plan originally provided that the aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2014 Plan may not exceed 450,000 shares (the &#8220;Share Reserve&#8221;), however in October 2015, the stockholders approved a 1,500,000 increase to the Share Reserve. In addition, the Share Reserve automatically increases on January 1st of each year, for a period of not more than 10 years, beginning on January 1st of the year following the year in which the 2014 Plan became effective and ending on (and including) January 1, 2024, in an amount equal to 4% of the total number of shares of common stock outstanding on December 31st of the preceding calendar year. The Company&#8217;s Board of Directors may act prior to January 1st of a given year to provide that there will be no January 1st increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser number of shares of common stock than would otherwise occur. On January 1, 2015, the Share Reserve increased by 188,640 shares due to the automatic 4% increase. On January 1, 2016, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2017, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2018, the Share Reserve increased by 235,090 shares due to the automatic 4% increase. The Share Reserve is currently 2,783,616 shares as of March 31, 2019.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In light of stockholder approval of the 2014 Plan, the Company no longer grants equity awards under the 2007 Plan. As of March 31, 2019, 0 shares of an aggregate total of 407,500 shares were available for future stock-based compensation grants under the 2007 Plan and 987,337 shares of an aggregate total of 2,783,616 shares were available for future stock-based compensation grants under the 2014 Plan.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: center; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Aggregate intrinsic value represents the difference between the closing market value as of March 31, 2019 of the underlying common stock and the exercise price of outstanding, in-the-money options. A summary of the Company&#8217;s stock option activity and related information for the three months ended March 31, 2019 is as follows:</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="14" nowrap="nowrap">Options&#160;Outstanding</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Number&#160;of<br />Stock Options<br />Outstanding</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted<br />Average<br />Exercise&#160;Price</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted<br />Average<br />Remaining<br />Contractual<br />Term&#160;(In Years)</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Aggregate<br />Intrinsic&#160;Value<br />&#160;(in thousands)</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="width: 753px; font-weight: bold;">Balance, January 1, 2019</td> <td style="width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: left; width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: right; width: 157px; font-weight: bold;">1,761,447</td> <td style="text-align: left; width: 16px; font-weight: bold;">&#160;</td> <td style="width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: left; width: 16px; font-weight: bold;">$</td> <td style="text-align: right; width: 157px; font-weight: bold;">3.18</td> <td style="text-align: left; width: 16px; font-weight: bold;">&#160;</td> <td style="width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: left; width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: right; width: 156px; font-weight: bold;">6.84</td> <td style="text-align: left; width: 15px; font-weight: bold;">&#160;</td> <td style="width: 15px; font-weight: bold;">&#160;</td> <td style="text-align: left; width: 15px; font-weight: bold;">$</td> <td style="text-align: right; width: 156px; font-weight: bold;">55,000</td> <td style="text-align: left; width: 15px; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Options exercised</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(6,162</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">2.10</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="font-weight: bold;">Balance, March 31, 2019</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">1,755,285</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">3.18</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">6.59</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">69,492</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="font-weight: bold;">Exercisable as of March 31, 2019</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">1,554,102</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">2.99</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">6.41</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">61,827</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The total compensation cost related to unvested stock option awards not yet recognized was $693 as of March 31, 2019. The weighted average period over which the total unrecognized compensation cost related to these unvested stock awards will be recognized is 1.33 years.&#160;<font style="color: #231f20;">The weighted average fair value of options granted during the three months ended March 31, 2018 was $5.97 per share, or an aggregate grant date fair value of $806</font>. There were no options granted during the three months ended March 31, 2019.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 19.95pt; margin: 0pt 0px 0pt 5.85pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On January 2, 2018 the Compensation Committee of the Company&#8217;s Board of Directors granted, and the full Board ratified, an option to acquire an aggregate of 125,000 shares under the 2014 Plan to the Company&#8217;s CEO. This option vests 25% on the one-year anniversary of the grant date and monthly thereafter for 36 months, such that the option is vested in full on the four-year anniversary of the grant date. On January 2, 2018 the Company&#8217;s Compensation Committee granted, and the full Board ratified, options to each of the then-seated non-employee Directors to acquire 5,000 shares, for an aggregate of 10,000 shares, under the 2014 Plan. These options vest on the one-year anniversary of their grant date. On February 28, 2018 the Compensation Committee of the Company&#8217;s Board of Directors accelerated the vesting on stock options issued to consultants such that all unvested shares were vested on that date. This resulted in a one-time expense of $49 during the three months ended March 31, 2018.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>Determining the Fair Value of Stock Options</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company uses the Black-Scholes pricing model to determine the fair value of stock options. The fair value of each option grant is estimated on the date of the grant. There were no stock options granted during the three months ended March 31, 2019. There were 135,000 stock options granted during the three months ended March 31, 2018. The following assumptions for the periods presented were:</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 80%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three months ended March 31,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="padding-bottom: 1pt;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 928px;">Expected term (in years)</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="text-align: right; width: 126px;">-</td> <td style="text-align: left; width: 12px;"></td> <td style="width: 12px;">&#160;</td> <td style="text-align: left; width: 12px;">&#160;</td> <td style="text-align: right; width: 125px;">5</td> <td style="text-align: left; width: 12px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Risk-free interest rate</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">2.2</td> <td style="text-align: left;">%</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left;">Expected volatility</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">0.99</td> <td style="text-align: left;">%</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Expected dividend rate</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The assumptions are based on the following for each of the periods presented:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Valuation Method</i>&#160;&#8212; The Company estimates the fair value of its stock options using the Black-Scholes option pricing model.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Expected Term</i>&#160;&#8212; The Company estimates the expected term consistent with the simplified method identified by the SEC. The Company elected to use the simplified method because of its limited history of stock option exercise activity and its stock options meet the criteria of the &#8220;plain-vanilla&#8221; options as defined by the SEC. The simplified method calculates the expected term as the average of the vesting and contractual terms of the award.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Volatility</i>&#160;&#8212; The Company derives this number from the historical stock volatilities of the Company&#8217;s stock over a period approximately equal to the expected term of the options.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Risk-free Interest Rate</i>&#160;&#8212; The risk-free interest rate is based on median U.S. Treasury zero coupon issues with remaining terms similar to the expected term on the options.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Expected Dividend&#160;</i>&#8212; The Company has never declared or paid any cash dividends and does not plan to pay cash dividends in the foreseeable future, and therefore, used an expected dividend yield of zero in the valuation model.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Forfeiture</i>&#160;&#8212; Beginning in the first quarter of 2017, the Company implemented ASU 2016-09, and elected to true-up calculations at the time of forfeiture, rather than creating an estimate at the time of option issuance.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company has recorded an expense of&#160;<font style="color: #231f20;">$98 and $193&#160;</font>as it relates to stock-based compensation for the three months ended March 31, 2019 and 2018, respectively:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 80%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three months&#160;ended March 31,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="width: 928px;">Cost of Revenue</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 126px;">1</td> <td style="text-align: left; width: 12px;">&#160;</td> <td style="width: 12px;">&#160;</td> <td style="text-align: left; width: 12px;">$</td> <td style="text-align: right; width: 125px;">1</td> <td style="text-align: left; width: 12px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Engineering and Product Development</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">8</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left;">Sales and Marketing</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">15</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">29</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">General and Administrative</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">75</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">155</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="padding-bottom: 2.5pt;">Total</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">98</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">193</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 35.45pt;"><b>8.</b></td> <td><b>Net Income Per Share, Basic and Diluted</b></td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Basic earnings per share (&#8220;EPS&#8221;) represent net income attributable to common stockholders divided by the weighted average number of common shares outstanding during the measurement period. Diluted EPS represents net income attributable to common stockholders divided by the weighted average number of common shares outstanding during the measurement period while also giving effect to all potentially dilutive common shares that were outstanding during the period using the treasury stock method.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Basic and diluted net EPS is calculated as follows:</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="22" nowrap="nowrap">Three months ended March 31,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 345px;">Basic EPS</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="text-align: right; width: 157px;">6,326,149</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 157px;">1,854</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 157px;">0.29</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="text-align: right; width: 157px;">5,924,701</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 156px;">706</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 156px;">0.12</td> <td style="text-align: left; width: 15px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Common stock warrants</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">246,843</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">225,154</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Common stock options</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">1,597,295</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">&#160;</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">1,130,637</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">&#160;</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Diluted EPS</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">8,170,287</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">1,854</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.23</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7,280,492</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">706</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.10</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The following weighted average shares outstanding of common stock equivalents were excluded from the computation of diluted net loss per share for the three months ended March 31, 2019 and 2018 because including them would have been anti-dilutive:</p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 70%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three months ended<br />March 31,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td nowrap="nowrap">Weighted average shares outstanding:</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; width: 754px;">Common stock warrants</td> <td style="width: 11px;">&#160;</td> <td style="text-align: left; width: 11px;">&#160;</td> <td style="text-align: right; width: 101px;">-</td> <td style="text-align: left; width: 10px;">&#160;</td> <td style="width: 10px;">&#160;</td> <td style="text-align: left; width: 10px;">&#160;</td> <td style="text-align: right; width: 101px;">71,500</td> <td style="text-align: left; width: 10px;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="padding-bottom: 1pt;">Options</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">135,000</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-bottom: 2.5pt;">Total</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: right;">206,500</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td><b>Basis of Presentation</b></td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Semler Scientific, Inc., a Delaware corporation (&#8220;Semler&#8221; or &#8220;the Company&#8221;), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (&#8220;GAAP&#8221;) and applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company&#8217;s annual report on Form 10-K for the year ended December 31, 2018 filed with the SEC on March 7, 2019 (the &#8220;Annual Report&#8221;). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>Recently Issued Accounting Pronouncements</b></p> <p style="widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Accounting Pronouncements Recently Adopted</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>&#160;</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) No. 2014-09, Revenue from Contracts with Customers (&#8220;ASU No. 2014-09&#8221;). The amendment in this ASU provides guidance on the revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The core principle of this update provides guidance to identify the performance obligations under the contract(s) with a customer and how to allocate the transaction price to the performance obligations in the contract. It further provides guidance to recognize revenue when (or as) the entity satisfies a performance obligation. This standard will replace most existing revenue recognition guidance. On August 8, 2015, the FASB issued ASU 2015-14, which defers the effective date of ASU No. 2014-09 by one year, and permits early adoption as long as the adoption date is not before the original public entity effective date. Since the issuance of ASU 2014-09, the FASB has issued several amendments that clarify certain points, including ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Identifying Performance Obligations and Licensing, ASU 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 Emerging Issues Task Force Meeting, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients, and ASU No. 2016-20, Technical Corrections and Improvements to Topic 606. The updated revenue standard allows two methods of adoption: (1) retrospectively to each prior period presented (&#8220;full retrospective method&#8221;), or (2) retrospectively with the cumulative effect recognized in retained earnings as of the date of adoption (&#8220;modified retrospective method&#8221;). The new standard further requires new disclosures about contracts with customers, including the significant judgments the company has made when applying the guidance. The Company adopted the new standard effective January 1, 2019, using the modified retrospective transition method. The Company determined that the adoption of this new standard did not have a material impact on its financial statements.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Topic 606 affects revenue recognition for the Company&#8217;s variable license fee contracts, which represents approximately $1,500 and $750 of revenue for the quarters ended March 31, 2019 and 2018, respectively. Essentially all of the variable license fee contracts are with large healthcare organizations. The remainder of the revenue is earned from leasing the Company's testing product for a fixed monthly fee, which is not subject to Topic 606. It was determined that the impact of the new standard has no effect on the way revenue was currently being recognized. Reusable hardware equipment or accessories may be provided to a customer for a set price and then use of the associated software is billed to the customer monthly based on volume of use. Under this scenario, revenue is recognized when and only when the customer uses the product. The Company is rendering a service and recognizes revenue in direct proportion to how much service is rendered. The sale of the equipment or accessories is recognized as hardware sales upon shipment to the customer. The initial contract is for a specified time period with automatic renewal each period thereafter until canceled. In case there is a violation of any term of the contract, the Company may deactivate the service remotely, so that the customer cannot continue to use the product.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Accounting Pronouncements Not Yet Adopted</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In January 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU No. 2016-02"). Under the new guidance in ASU No. 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee&#8217;s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee&#8217;s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged, however, certain targeted improvements were made. ASU No. 2016-02 also simplifies the accounting for sale and leaseback transactions. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The new standard also requires expanded disclosures regarding leasing arrangements. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements. This ASU provides another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date and recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. This ASU also provides further guidance on lessors accounting policy election to not separate non-lease components from the associated lease components and limits this to circumstances in which the non-lease component or components otherwise would be accounted for under the new revenue guidance and both (1) the timing and pattern of transfer are the same for the non-lease component(s) and associated lease component, and (2) the lease component, if accounted for separately, would be classified as a an operating lease. In December 2018, the FASB issued ASU No. 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors. This ASU provide narrow scope improvements for lessor accounting by permitting lessors, as an accounting policy election, to treat certain sales taxes and other similar taxes as lessee costs, to exclude lessor costs paid by lessees directly to third parties from variable payments, and clarify the accounting by lessors for variable payments that related to both a lease component and a nonlease component. In January 2019, the FASB issued ASU No. 2019-01, Leases Codification Improvements, which reinstates the exception for lessors that are not manufacturers or dealers for determining fair value of the leased property as the underlying asset&#8217;s cost, clarifies the presentation on the statement of cash flows for sales type and direct financing leases for lessors that are depository and lending institutions and clarifies the transition disclosures related to accounting changes and error corrections in the year of adoption of the ASU. This update is effective for the Company&#8217;s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (&#8220;ASU 2016-13&#8221;). This ASU requires timelier recording of credit losses on loans and other financial instruments held. Instead of reserves based on a current probability analysis, ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. All organizations will now use forward-looking information to better inform their credit loss estimates. ASU 2016-13 requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization&#8217;s portfolio. These disclosures include qualitative and quantitative requirements that provide information about the amounts recorded in the financial statements. In addition, ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. This standard is effective for the Company&#8217;s fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the effect the new standard will have on its financial statements.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In June 2018, the FASB issued ASU No. 2018-07, Compensation&#8212;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (&#8220;ASU 2018-07&#8221;). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of costs. The ASU specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor&#8217;s own operations by issuing share-based payment awards. This standard is effective for the Company&#8217;s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework&#8212;Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this ASU modify the disclosure requirements on fair value measurements removing the requirements to disclosure amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. In addition, it modified certain disclosures related to Level 3 fair value measurements and added additional disclosures regarding the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements and the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period. This update is effective for the Company&#8217;s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this update to have a material impact on its financial statements.</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 85%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">March 31,&#160;<br />2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,&#160;<br />2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 985px;">Assets for lease</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 133px;">2,568</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 133px;">2,218</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Less: accumulated depreciation</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(1,050</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(975</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2.5pt;">Assets for lease, net</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">1,518</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">1,243</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 85%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">March 31,&#160;<br />2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,&#160;<br />2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 985px;">Capital assets</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 133px;">488</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 133px;">457</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Less: accumulated depreciation</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(268</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(234</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2.5pt;">Capital assets, net</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">220</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">223</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 85%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">March 31,&#160;<br />2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,&#160;<br />2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="width: 985px;">Compensation</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 133px;">1,450</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 133px;">2,442</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Miscellaneous accruals</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">356</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">355</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2.5pt;">Total accrued expenses</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">1,806</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">2,797</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="14" nowrap="nowrap">Options&#160;Outstanding</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Number&#160;of<br />Stock Options<br />Outstanding</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted<br />Average<br />Exercise&#160;Price</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted<br />Average<br />Remaining<br />Contractual<br />Term&#160;(In Years)</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Aggregate<br />Intrinsic&#160;Value<br />&#160;(in thousands)</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="width: 753px; font-weight: bold;">Balance, January 1, 2019</td> <td style="width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: left; width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: right; width: 157px; font-weight: bold;">1,761,447</td> <td style="text-align: left; width: 16px; font-weight: bold;">&#160;</td> <td style="width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: left; width: 16px; font-weight: bold;">$</td> <td style="text-align: right; width: 157px; font-weight: bold;">3.18</td> <td style="text-align: left; width: 16px; font-weight: bold;">&#160;</td> <td style="width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: left; width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: right; width: 156px; font-weight: bold;">6.84</td> <td style="text-align: left; width: 15px; font-weight: bold;">&#160;</td> <td style="width: 15px; font-weight: bold;">&#160;</td> <td style="text-align: left; width: 15px; font-weight: bold;">$</td> <td style="text-align: right; width: 156px; font-weight: bold;">55,000</td> <td style="text-align: left; width: 15px; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Options exercised</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(6,162</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">2.10</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="font-weight: bold;">Balance, March 31, 2019</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">1,755,285</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">3.18</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">6.59</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">69,492</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="font-weight: bold;">Exercisable as of March 31, 2019</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">1,554,102</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">2.99</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">6.41</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">61,827</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> </table> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 80%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three months ended March 31,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="padding-bottom: 1pt;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 928px;">Expected term (in years)</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="text-align: right; width: 126px;">-</td> <td style="text-align: left; width: 12px;"></td> <td style="width: 12px;">&#160;</td> <td style="text-align: left; width: 12px;">&#160;</td> <td style="text-align: right; width: 125px;">5</td> <td style="text-align: left; width: 12px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Risk-free interest rate</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">2.2</td> <td style="text-align: left;">%</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left;">Expected volatility</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">0.99</td> <td style="text-align: left;">%</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Expected dividend rate</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> </tr> </table> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 80%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three months&#160;ended March 31,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="width: 928px;">Cost of Revenue</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 126px;">1</td> <td style="text-align: left; width: 12px;">&#160;</td> <td style="width: 12px;">&#160;</td> <td style="text-align: left; width: 12px;">$</td> <td style="text-align: right; width: 125px;">1</td> <td style="text-align: left; width: 12px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Engineering and Product Development</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">8</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left;">Sales and Marketing</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">15</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">29</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">General and Administrative</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">75</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">155</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="padding-bottom: 2.5pt;">Total</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">98</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">193</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="22" nowrap="nowrap">Three months ended March 31,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 345px;">Basic EPS</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="text-align: right; width: 157px;">6,326,149</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 157px;">1,854</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 157px;">0.29</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="text-align: right; width: 157px;">5,924,701</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 156px;">706</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 156px;">0.12</td> <td style="text-align: left; width: 15px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Common stock warrants</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">246,843</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">225,154</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Common stock options</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">1,597,295</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">&#160;</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">1,130,637</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">&#160;</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Diluted EPS</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">8,170,287</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">1,854</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.23</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7,280,492</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">706</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.10</td> <td style="text-align: left;">&#160;</td> </tr> </table> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 70%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three months ended<br />March 31,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td nowrap="nowrap">Weighted average shares outstanding:</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; width: 754px;">Common stock warrants</td> <td style="width: 11px;">&#160;</td> <td style="text-align: left; width: 11px;">&#160;</td> <td style="text-align: right; width: 101px;">-</td> <td style="text-align: left; width: 10px;">&#160;</td> <td style="width: 10px;">&#160;</td> <td style="text-align: left; width: 10px;">&#160;</td> <td style="text-align: right; width: 101px;">71,500</td> <td style="text-align: left; width: 10px;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="padding-bottom: 1pt;">Options</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">135,000</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-bottom: 2.5pt;">Total</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: right;">206,500</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> 2218000 975000 87000 109000 33000 35000 457000 488000 234000 268000 24000 34000 2442000 1450000 355000 356000 2 2 2 0.582 0.119 0.556 0.125 0.418 0.223 17000 17000 1761447 1755285 34615 6162 6162 1554102 3.18 3.18 2.10 2.99 P6Y10M2D P6Y7M2D P6Y4M28D 55000000 69492000 61827000 P5Y 0.022 0.000 0.0099 0.000 0.000 0.000 193000 1000 8000 29000 155000 98000 1000 7000 15000 75000 5000 125000 10000 2783616 P10Y 188640 1500000 204943 204943 235090 0.0400 0.0400 0.04 0.04 0.04 693000 P1Y3M29D 5.97 806000 0.25 P1Y P4Y 225154 246843 1130637 1597295 706000 1854000 0 0 0 0 706000 1854000 206500 71500 135000 0 0 0 95000 95000 13000 13000 5902244 5969834 -25000 -25000 6349985 6356147 -25000 -25000 64000 64000 32975 193000 193000 98000 98000 750000 1500000 2568000 1050000 0001554859smlr:CustomerOneConcentrationRiskMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2018-01-012018-12-31 0.435 0001554859smlr:CustomerTwoConcentrationRiskMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2018-01-012018-12-31 0.404 0001554859smlr:VendorOneMemberus-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMember2018-01-012018-12-31 0.110 0001554859smlr:VendorTwoMemberus-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMember2018-01-012018-12-31 0.108 0001554859smlr:VendorOneMemberus-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMember2019-01-012019-03-31 0.233 0001554859smlr:VendorTwoMemberus-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMember2019-01-012019-03-31 0.203 0001554859smlr:VendorThreeMemberus-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMember2019-01-012019-03-31 0.111 smlr:Vendor 0001554859us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMember2018-01-012018-12-31 2 0001554859us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMember2019-01-012019-03-31 3 0001554859us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2018-01-012018-12-31 2 987337 0001554859us-gaap:EmployeeStockOptionMembersmlr:StockIncentivePlan2014Member2014-09-30 450000 0001554859us-gaap:EmployeeStockOptionMembersmlr:KeyPersonStockOptionPlan2007Member2019-03-31 0 407500 49000 135000 This Amendment No. 1 on Form 10-Q/A to the Semler Scientific, Inc. (the “Company”) Quarterly Report on Form 10-Q, as originally filed with the Securities and Exchange Commission on May 3, 2019 (the “Original Filing”), is being filed solely to correct transposition errors in Note 5 Concentration of Credit Risk of the Notes to Condensed Consolidated Financial Statements included within Item 1. The revenues and accounts receivables percentages for the Company’s largest customers for the three months ended March 31, 2019 were inadvertently transposed in the Original Filing. Except as described above, no other changes have been made to the Original Filing and this Form 10-Q/A does not does reflect subsequent events that may have occurred since the date of the Original Filing or amend, update or change the financial statements or any other items or disclosures in the Original Filing. In accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended, we have included new certifications from our Principal Executive Officer and Principal Financial Officer dated the date of this Form 10-Q/A. EX-101.SCH 6 smlr-20190331.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Statements of Income (Unaudited) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Statements of Stockholders' Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Going Concern link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Assets for Lease, net link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Property and Equipment, net link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Accrued Expenses link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Concentration of Credit Risk link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Stock Option Plan link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Net Income Per Share, Basic and Diluted link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Summary of Significant Accounting Policies and Estimates (Policies) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Assets for Lease, net (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Property and Equipment, net (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Stock Option Plan (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Net Income Per Share, Basic and Diluted (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Basis of Presentation (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Assets for Lease, net - Summary of assets for lease (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Assets for Lease, net (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Property and Equipment, net (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Property and Equipment, net (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Accrued Expenses - Summary of accrued expenses (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Accrued Expenses (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Concentration of Credit Risk (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Commitments and Contingencies (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Stock Option Plan - Summary of stock-based compensation activity (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Stock Option Plan - Weighted-average Black-Scholes fair value assumptions (Details 1) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Stock Option Plan - Stock-based compensation (Details 2) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Stock Option Plan (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Net Income Per Share, Basic and Diluted (Details) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Net Income Per Share, Basic and Diluted (Details 1) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 smlr-20190331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 smlr-20190331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 smlr-20190331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 smlr-20190331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.19.1
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2019
May 01, 2019
Document And Entity Information [Abstract]    
Entity Registrant Name Semler Scientific, Inc.  
Entity Central Index Key 0001554859  
Trading Symbol smlr  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock, Shares Outstanding   6,331,147
Document Type 10-Q/A  
Document Period End Date Mar. 31, 2019  
Amendment Flag true  
Amendment Description This Amendment No. 1 on Form 10-Q/A to the Semler Scientific, Inc. (the “Company”) Quarterly Report on Form 10-Q, as originally filed with the Securities and Exchange Commission on May 3, 2019 (the “Original Filing”), is being filed solely to correct transposition errors in Note 5 Concentration of Credit Risk of the Notes to Condensed Consolidated Financial Statements included within Item 1. The revenues and accounts receivables percentages for the Company’s largest customers for the three months ended March 31, 2019 were inadvertently transposed in the Original Filing. Except as described above, no other changes have been made to the Original Filing and this Form 10-Q/A does not does reflect subsequent events that may have occurred since the date of the Original Filing or amend, update or change the financial statements or any other items or disclosures in the Original Filing. In accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended, we have included new certifications from our Principal Executive Officer and Principal Financial Officer dated the date of this Form 10-Q/A.  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q1  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Statements of Income (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Revenues $ 6,761 $ 4,463
Operating expenses:    
Cost of revenues 896 704
Engineering and product development 569 367
Sales and marketing 2,070 1,705
General and administrative 1,372 874
Total operating expenses 4,907 3,650
Income from operations 1,854 813
Interest expense, net   (32)
Related party interest expense   (75)
Other expense   (107)
Net income $ 1,854 $ 706
Net income per share:    
Basic (in dollars per share) $ 0.29 $ 0.12
Diluted (in dollars per share) $ 0.23 $ 0.10
Weighted average number of shares used in computing basic and diluted income per share:    
Basic (in shares) 6,326,149 5,924,701
Diluted (in shares) 8,170,287 7,280,492
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current Assets:    
Cash $ 4,544 $ 3,284
Trade accounts receivable, net of allowance for doubtful accounts of $52 and $52, respectively 2,533 2,801
Prepaid expenses and other current assets 225 153
Total current assets 7,302 6,238
Assets for lease, net 1,518 1,243
Property and equipment, net 220 223
Long-term deposits 15 15
Total assets 9,055 7,719
Current liabilities:    
Accounts payable 257 280
Accrued expenses 1,806 2,797
Deferred revenue 821 435
Total current liabilities 2,884 3,512
Long-term liabilities:    
Deferred rent 10 11
Total long-term liabilities 10 11
Stockholders' equity:    
Common stock, $0.001 par value; 50,000,000 shares authorized; 6,356,147 and 6,349,985 shares issued, and 6,331,147 and 6,324,985 outstanding (treasury shares of 25,000 and 25,000), respectively 6 6
Additional paid-in capital 25,719 25,608
Accumulated deficit (19,564) (21,418)
Total stockholders' equity 6,161 4,196
Total liabilities and stockholders' equity $ 9,055 $ 7,719
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts on trade accounts receivable (in dollars) $ 52 $ 52
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 50,000,000 50,000,000
Common stock, shares issued 6,356,147 6,349,985
Common stock, shares outstanding 6,331,147 6,324,985
Treasury stock, shares 25,000 25,000
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2017 $ 6   $ 23,844 $ (26,432) $ (2,582)
Balance (in shares) at Dec. 31, 2017 5,902,244 (25,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Warrant Exercises     64   64
Warrant Exercises (in shares) 32,975        
Stock Option Exercises     95   95
Stock Option Exercises (in shares) 34,615        
Stock-based Compensation     193   193
Net income       706 706
Balance at Mar. 31, 2018 $ 6   24,196 (25,726) (1,524)
Balance (in shares) at Mar. 31, 2018 5,969,834 (25,000)      
Balance at Dec. 31, 2018 $ 6   25,608 (21,418) 4,196
Balance (in shares) at Dec. 31, 2018 6,349,985 (25,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock Option Exercises     13   $ 13
Stock Option Exercises (in shares) 6,162       6,162
Stock-based Compensation     98   $ 98
Net income       1,854 1,854
Balance at Mar. 31, 2019 $ 6   $ 25,719 $ (19,564) $ 6,161
Balance (in shares) at Mar. 31, 2019 6,356,147 (25,000)      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 1,854 $ 706
Reconciliation of Net Income to Net Cash Provided by (Used in) Operating Activities:    
Amortization of debt discount   13
Accretion of non-cash interest   65
Depreciation 143 121
Loss on disposal of assets for lease 34 69
Bad debt expense 6 3
Stock-based compensation expense 98 193
Changes in Operating Assets and Liabilities:    
Trade accounts receivable 268 (1,064)
Prepaid expenses and other current assets (72) (93)
Accounts payable (23) (147)
Accrued expenses (991) (501)
Deferred revenue 386 269
Net Cash Provided by (Used in) Operating Activities 1,703 (366)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Additions to property and equipment (31) (34)
Purchase of assets for lease, net (425) (58)
Net Cash Used in Investing Activities (456) (92)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Exercise of warrants   64
Exercise of stock options 13 95
Payments of loans payable   (739)
Net Cash Provided by (Used in) Financing Activities 13 (580)
INCREASE (DECREASE) IN CASH 1,260 (1,038)
CASH, BEGINNING OF PERIOD 3,284 1,457
CASH, END OF PERIOD $ 4,544 419
Cash paid for interest   $ 142
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Basis of Presentation
 3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Basis of Presentation
1. Basis of Presentation

 

Semler Scientific, Inc., a Delaware corporation (“Semler” or “the Company”), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2018 filed with the SEC on March 7, 2019 (the “Annual Report”). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.

 

Recently Issued Accounting Pronouncements

 

Accounting Pronouncements Recently Adopted

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“ASU No. 2014-09”). The amendment in this ASU provides guidance on the revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The core principle of this update provides guidance to identify the performance obligations under the contract(s) with a customer and how to allocate the transaction price to the performance obligations in the contract. It further provides guidance to recognize revenue when (or as) the entity satisfies a performance obligation. This standard will replace most existing revenue recognition guidance. On August 8, 2015, the FASB issued ASU 2015-14, which defers the effective date of ASU No. 2014-09 by one year, and permits early adoption as long as the adoption date is not before the original public entity effective date. Since the issuance of ASU 2014-09, the FASB has issued several amendments that clarify certain points, including ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Identifying Performance Obligations and Licensing, ASU 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 Emerging Issues Task Force Meeting, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients, and ASU No. 2016-20, Technical Corrections and Improvements to Topic 606. The updated revenue standard allows two methods of adoption: (1) retrospectively to each prior period presented (“full retrospective method”), or (2) retrospectively with the cumulative effect recognized in retained earnings as of the date of adoption (“modified retrospective method”). The new standard further requires new disclosures about contracts with customers, including the significant judgments the company has made when applying the guidance. The Company adopted the new standard effective January 1, 2019, using the modified retrospective transition method. The Company determined that the adoption of this new standard did not have a material impact on its financial statements.

 

Topic 606 affects revenue recognition for the Company’s variable license fee contracts, which represents approximately $1,500 and $750 of revenue for the quarters ended March 31, 2019 and 2018, respectively. Essentially all of the variable license fee contracts are with large healthcare organizations. The remainder of the revenue is earned from leasing the Company's testing product for a fixed monthly fee, which is not subject to Topic 606. It was determined that the impact of the new standard has no effect on the way revenue was currently being recognized. Reusable hardware equipment or accessories may be provided to a customer for a set price and then use of the associated software is billed to the customer monthly based on volume of use. Under this scenario, revenue is recognized when and only when the customer uses the product. The Company is rendering a service and recognizes revenue in direct proportion to how much service is rendered. The sale of the equipment or accessories is recognized as hardware sales upon shipment to the customer. The initial contract is for a specified time period with automatic renewal each period thereafter until canceled. In case there is a violation of any term of the contract, the Company may deactivate the service remotely, so that the customer cannot continue to use the product.

  

Accounting Pronouncements Not Yet Adopted

 

In January 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU No. 2016-02"). Under the new guidance in ASU No. 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged, however, certain targeted improvements were made. ASU No. 2016-02 also simplifies the accounting for sale and leaseback transactions. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The new standard also requires expanded disclosures regarding leasing arrangements. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements. This ASU provides another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date and recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. This ASU also provides further guidance on lessors accounting policy election to not separate non-lease components from the associated lease components and limits this to circumstances in which the non-lease component or components otherwise would be accounted for under the new revenue guidance and both (1) the timing and pattern of transfer are the same for the non-lease component(s) and associated lease component, and (2) the lease component, if accounted for separately, would be classified as a an operating lease. In December 2018, the FASB issued ASU No. 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors. This ASU provide narrow scope improvements for lessor accounting by permitting lessors, as an accounting policy election, to treat certain sales taxes and other similar taxes as lessee costs, to exclude lessor costs paid by lessees directly to third parties from variable payments, and clarify the accounting by lessors for variable payments that related to both a lease component and a nonlease component. In January 2019, the FASB issued ASU No. 2019-01, Leases Codification Improvements, which reinstates the exception for lessors that are not manufacturers or dealers for determining fair value of the leased property as the underlying asset’s cost, clarifies the presentation on the statement of cash flows for sales type and direct financing leases for lessors that are depository and lending institutions and clarifies the transition disclosures related to accounting changes and error corrections in the year of adoption of the ASU. This update is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This ASU requires timelier recording of credit losses on loans and other financial instruments held. Instead of reserves based on a current probability analysis, ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. All organizations will now use forward-looking information to better inform their credit loss estimates. ASU 2016-13 requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. These disclosures include qualitative and quantitative requirements that provide information about the amounts recorded in the financial statements. In addition, ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. This standard is effective for the Company’s fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the effect the new standard will have on its financial statements.

 

In June 2018, the FASB issued ASU No. 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of costs. The ASU specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. This standard is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.

 

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this ASU modify the disclosure requirements on fair value measurements removing the requirements to disclosure amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. In addition, it modified certain disclosures related to Level 3 fair value measurements and added additional disclosures regarding the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements and the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period. This update is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this update to have a material impact on its financial statements.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Assets for Lease, net
 3 Months Ended
Mar. 31, 2019
Leases, Capital [Abstract]  
Assets for Lease, net
2. Assets for Lease, net

 

Assets for lease consist of the following:

 

    March 31, 
2019		     December 31, 
2018		  
             
Assets for lease   $ 2,568     $ 2,218  
Less: accumulated depreciation     (1,050 )     (975 )
Assets for lease, net   $ 1,518     $ 1,243  

 

Depreciation expense amounted to $109 and $87 for the three months ended March 31, 2019 and 2018, respectively. Reduction to accumulated depreciation for returned items was $35 and $33 for the three months ended March 31, 2019 and 2018, respectively. The Company recognized a loss on disposal of assets for lease in the amount of $34 and $69 for the three months ended March 31, 2019 and 2018, respectively.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Property and Equipment, net
 3 Months Ended
Mar. 31, 2019
Property, Plant and Equipment [Abstract]  
Property and Equipment, net
3. Property and Equipment, net

 

Capital assets consist of the following:

 

    March 31, 
2019		     December 31, 
2018		  
             
Capital assets   $ 488     $ 457  
Less: accumulated depreciation     (268 )     (234 )
Capital assets, net   $ 220     $ 223  

 

Depreciation expense amounted to $34 and $24 for the three months ended March 31, 2019 and 2018, respectively.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.19.1
Accrued Expenses
 3 Months Ended
Mar. 31, 2019
Accrued Liabilities, Current [Abstract]  
Accrued Expenses
4. Accrued Expenses

 

Accrued expenses consist of the following:

 

    March 31, 
2019		     December 31, 
2018		  
             
Compensation   $ 1,450     $ 2,442  
Miscellaneous accruals     356       355  
Total accrued expenses   $ 1,806     $ 2,797  
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Concentration of Credit Risk
 3 Months Ended
Mar. 31, 2019
Risks and Uncertainties [Abstract]  
Concentration of Credit Risk
5. Concentration of Credit Risk

 

Credit risk is the risk of loss from amounts owed by the financial counterparties. Credit risk can occur at multiple levels; as a result of broad economic conditions, challenges within specific sectors of the economy, or from issues affecting individual companies. Financial instruments that potentially subject the Company to credit risk consist of cash and accounts receivable.

 

The Company maintains cash with major financial institutions. The Company’s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. The Company limits its credit risk by dealing with counterparties that are considered to be of high credit quality and by performing periodic evaluations of the relative credit standing of these financial institutions.

 

Management periodically monitors the creditworthiness of its customers and believes that it has adequately provided for any exposure to potential credit loss. For the three months ended March 31, 2018, two customers accounted for 58.2% and 11.9% of the Company’s revenue, respectively. For the three months ended March 31, 2019, two customers accounted for 55.6% and 12.5% of the Company’s revenue, respectively. As of December 31, 2018, two customers accounted for 43.5% and 40.4% of the Company’s accounts receivable, respectively. As of March 31, 2019, two customers accounted for 41.8% and 22.3% of the Company’s accounts receivable, respectively.  The Company’s largest customer in terms of both revenue and accounts receivable in the three months ended March 31, 2019 is a U.S. diversified healthcare company and its affiliated plans.

  

As of December 31, 2018, two vendors accounted for 11.0% and 10.8% of the Company’s accounts payable, respectively. As of March 31, 2019, three vendors accounted for 23.3%, 20.3%, and 11.1% of the Company’s accounts payable, respectively.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies
 3 Months Ended
Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
6. Commitments and Contingencies

 

Facilities Leases

 

The Company recognized facilities lease expenses of $17 and $17 for the three months ended March 31, 2019 and 2018, respectively.

 

Indemnification Obligations

 

The Company enters into agreements with customers, partners, lenders, consultants, lessors, contractors, sales representatives and parties to certain transactions in the ordinary course of the Company’s business. These agreements may require the Company to indemnify the other party against third party claims alleging that its product infringes a patent or copyright. Certain of these agreements require the Company to indemnify the other party against losses arising from: a breach of representations or covenants, claims relating to property damage, personal injury or acts or omissions of the Company, its employees, agents or representatives. The Company has also agreed to indemnify the directors and certain of the officers and employees in accordance with the by-laws of the Company. These indemnification provisions will vary based upon the nature and terms of the agreements. In many cases, these indemnification provisions do not contain limits on the Company’s liability, and the occurrence of contingent events that will trigger payment under these indemnities is difficult to predict. As a result, the Company cannot estimate its potential liability under these indemnities. The Company believes that the likelihood of conditions arising that would trigger these indemnities is remote and, historically, the Company had not made any significant payment under such indemnification provisions. Accordingly, the Company has not recorded any liabilities relating to these agreements. In certain cases, the Company has recourse against third parties with respect to the aforesaid indemnities, and the Company believes it maintains adequate levels of insurance coverage to protect the Company with respect to potential claims arising from such agreements.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.19.1
Stock Option Plan
 3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Option Plan
7. Stock Option Plan

 

The Company’s stock-based compensation program is designed to attract and retain employees while also aligning employees' interests with the interests of its stockholders. Stock options have been granted to employees under the stockholder-approved 2007 Key Person Stock Option Plan (“2007 Plan”) or the stockholder-approved 2014 Stock Incentive Plan (“2014 Plan”). Stockholder approval of the 2014 Plan became effective in September 2014. The 2014 Plan originally provided that the aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2014 Plan may not exceed 450,000 shares (the “Share Reserve”), however in October 2015, the stockholders approved a 1,500,000 increase to the Share Reserve. In addition, the Share Reserve automatically increases on January 1st of each year, for a period of not more than 10 years, beginning on January 1st of the year following the year in which the 2014 Plan became effective and ending on (and including) January 1, 2024, in an amount equal to 4% of the total number of shares of common stock outstanding on December 31st of the preceding calendar year. The Company’s Board of Directors may act prior to January 1st of a given year to provide that there will be no January 1st increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser number of shares of common stock than would otherwise occur. On January 1, 2015, the Share Reserve increased by 188,640 shares due to the automatic 4% increase. On January 1, 2016, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2017, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2018, the Share Reserve increased by 235,090 shares due to the automatic 4% increase. The Share Reserve is currently 2,783,616 shares as of March 31, 2019.

 

In light of stockholder approval of the 2014 Plan, the Company no longer grants equity awards under the 2007 Plan. As of March 31, 2019, 0 shares of an aggregate total of 407,500 shares were available for future stock-based compensation grants under the 2007 Plan and 987,337 shares of an aggregate total of 2,783,616 shares were available for future stock-based compensation grants under the 2014 Plan.

 

 

Aggregate intrinsic value represents the difference between the closing market value as of March 31, 2019 of the underlying common stock and the exercise price of outstanding, in-the-money options. A summary of the Company’s stock option activity and related information for the three months ended March 31, 2019 is as follows:

 

    Options Outstanding  
    Number of
Stock Options
Outstanding		     Weighted
Average
Exercise Price		     Weighted
Average
Remaining
Contractual
Term (In Years)		     Aggregate
Intrinsic Value
 (in thousands)		  
Balance, January 1, 2019     1,761,447     $ 3.18       6.84     $ 55,000  
Options exercised     (6,162 )     2.10                  
Balance, March 31, 2019     1,755,285     $ 3.18       6.59     $ 69,492  
Exercisable as of March 31, 2019     1,554,102     $ 2.99       6.41     $ 61,827  

 

The total compensation cost related to unvested stock option awards not yet recognized was $693 as of March 31, 2019. The weighted average period over which the total unrecognized compensation cost related to these unvested stock awards will be recognized is 1.33 years. The weighted average fair value of options granted during the three months ended March 31, 2018 was $5.97 per share, or an aggregate grant date fair value of $806. There were no options granted during the three months ended March 31, 2019.

 

On January 2, 2018 the Compensation Committee of the Company’s Board of Directors granted, and the full Board ratified, an option to acquire an aggregate of 125,000 shares under the 2014 Plan to the Company’s CEO. This option vests 25% on the one-year anniversary of the grant date and monthly thereafter for 36 months, such that the option is vested in full on the four-year anniversary of the grant date. On January 2, 2018 the Company’s Compensation Committee granted, and the full Board ratified, options to each of the then-seated non-employee Directors to acquire 5,000 shares, for an aggregate of 10,000 shares, under the 2014 Plan. These options vest on the one-year anniversary of their grant date. On February 28, 2018 the Compensation Committee of the Company’s Board of Directors accelerated the vesting on stock options issued to consultants such that all unvested shares were vested on that date. This resulted in a one-time expense of $49 during the three months ended March 31, 2018.

 

Determining the Fair Value of Stock Options

 

The Company uses the Black-Scholes pricing model to determine the fair value of stock options. The fair value of each option grant is estimated on the date of the grant. There were no stock options granted during the three months ended March 31, 2019. There were 135,000 stock options granted during the three months ended March 31, 2018. The following assumptions for the periods presented were:

 

    Three months ended March 31,  
    2019     2018  
             
Expected term (in years)     -     5  
Risk-free interest rate     - %     2.2 %
Expected volatility     - %     0.99 %
Expected dividend rate     - %     - %

 

The assumptions are based on the following for each of the periods presented:

 

Valuation Method — The Company estimates the fair value of its stock options using the Black-Scholes option pricing model.

 

Expected Term — The Company estimates the expected term consistent with the simplified method identified by the SEC. The Company elected to use the simplified method because of its limited history of stock option exercise activity and its stock options meet the criteria of the “plain-vanilla” options as defined by the SEC. The simplified method calculates the expected term as the average of the vesting and contractual terms of the award.

 

Volatility — The Company derives this number from the historical stock volatilities of the Company’s stock over a period approximately equal to the expected term of the options.

  

Risk-free Interest Rate — The risk-free interest rate is based on median U.S. Treasury zero coupon issues with remaining terms similar to the expected term on the options.

 

Expected Dividend — The Company has never declared or paid any cash dividends and does not plan to pay cash dividends in the foreseeable future, and therefore, used an expected dividend yield of zero in the valuation model.

 

Forfeiture — Beginning in the first quarter of 2017, the Company implemented ASU 2016-09, and elected to true-up calculations at the time of forfeiture, rather than creating an estimate at the time of option issuance.

 

The Company has recorded an expense of $98 and $193 as it relates to stock-based compensation for the three months ended March 31, 2019 and 2018, respectively:

 

    Three months ended March 31,  
    2019     2018  
Cost of Revenue   $ 1     $ 1  
Engineering and Product Development     7       8  
Sales and Marketing     15       29  
General and Administrative     75       155  
Total   $ 98     $ 193  
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Net Income Per Share, Basic and Diluted
 3 Months Ended
Mar. 31, 2019
Earnings Per Share [Abstract]  
Net Income Per Share, Basic and Diluted
8. Net Income Per Share, Basic and Diluted

 

Basic earnings per share (“EPS”) represent net income attributable to common stockholders divided by the weighted average number of common shares outstanding during the measurement period. Diluted EPS represents net income attributable to common stockholders divided by the weighted average number of common shares outstanding during the measurement period while also giving effect to all potentially dilutive common shares that were outstanding during the period using the treasury stock method.

 

Basic and diluted net EPS is calculated as follows:

 

    Three months ended March 31,  
    2019     2018  
    Shares     Net Income     EPS     Shares     Net Income     EPS  
Basic EPS     6,326,149     $ 1,854     $ 0.29       5,924,701     $ 706     $ 0.12  
Common stock warrants     246,843       -               225,154       -          
Common stock options     1,597,295       -               1,130,637       -          
Diluted EPS     8,170,287     $ 1,854     $ 0.23       7,280,492     $ 706     $ 0.10  

 

The following weighted average shares outstanding of common stock equivalents were excluded from the computation of diluted net loss per share for the three months ended March 31, 2019 and 2018 because including them would have been anti-dilutive:

 

    Three months ended
March 31,		  
    2019     2018  
Weighted average shares outstanding:            
Common stock warrants     -       71,500  
Options     -       135,000  
Total     -       206,500  
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies and Estimates (Policies)
 3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation

 

Semler Scientific, Inc., a Delaware corporation (“Semler” or “the Company”), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2018 filed with the SEC on March 7, 2019 (the “Annual Report”). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.
Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

Accounting Pronouncements Recently Adopted

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“ASU No. 2014-09”). The amendment in this ASU provides guidance on the revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The core principle of this update provides guidance to identify the performance obligations under the contract(s) with a customer and how to allocate the transaction price to the performance obligations in the contract. It further provides guidance to recognize revenue when (or as) the entity satisfies a performance obligation. This standard will replace most existing revenue recognition guidance. On August 8, 2015, the FASB issued ASU 2015-14, which defers the effective date of ASU No. 2014-09 by one year, and permits early adoption as long as the adoption date is not before the original public entity effective date. Since the issuance of ASU 2014-09, the FASB has issued several amendments that clarify certain points, including ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Identifying Performance Obligations and Licensing, ASU 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 Emerging Issues Task Force Meeting, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients, and ASU No. 2016-20, Technical Corrections and Improvements to Topic 606. The updated revenue standard allows two methods of adoption: (1) retrospectively to each prior period presented (“full retrospective method”), or (2) retrospectively with the cumulative effect recognized in retained earnings as of the date of adoption (“modified retrospective method”). The new standard further requires new disclosures about contracts with customers, including the significant judgments the company has made when applying the guidance. The Company adopted the new standard effective January 1, 2019, using the modified retrospective transition method. The Company determined that the adoption of this new standard did not have a material impact on its financial statements.

 

Topic 606 affects revenue recognition for the Company’s variable license fee contracts, which represents approximately $1,500 and $750 of revenue for the quarters ended March 31, 2019 and 2018, respectively. Essentially all of the variable license fee contracts are with large healthcare organizations. The remainder of the revenue is earned from leasing the Company's testing product for a fixed monthly fee, which is not subject to Topic 606. It was determined that the impact of the new standard has no effect on the way revenue was currently being recognized. Reusable hardware equipment or accessories may be provided to a customer for a set price and then use of the associated software is billed to the customer monthly based on volume of use. Under this scenario, revenue is recognized when and only when the customer uses the product. The Company is rendering a service and recognizes revenue in direct proportion to how much service is rendered. The sale of the equipment or accessories is recognized as hardware sales upon shipment to the customer. The initial contract is for a specified time period with automatic renewal each period thereafter until canceled. In case there is a violation of any term of the contract, the Company may deactivate the service remotely, so that the customer cannot continue to use the product.

  

Accounting Pronouncements Not Yet Adopted

 

In January 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU No. 2016-02"). Under the new guidance in ASU No. 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged, however, certain targeted improvements were made. ASU No. 2016-02 also simplifies the accounting for sale and leaseback transactions. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The new standard also requires expanded disclosures regarding leasing arrangements. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements. This ASU provides another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date and recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. This ASU also provides further guidance on lessors accounting policy election to not separate non-lease components from the associated lease components and limits this to circumstances in which the non-lease component or components otherwise would be accounted for under the new revenue guidance and both (1) the timing and pattern of transfer are the same for the non-lease component(s) and associated lease component, and (2) the lease component, if accounted for separately, would be classified as a an operating lease. In December 2018, the FASB issued ASU No. 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors. This ASU provide narrow scope improvements for lessor accounting by permitting lessors, as an accounting policy election, to treat certain sales taxes and other similar taxes as lessee costs, to exclude lessor costs paid by lessees directly to third parties from variable payments, and clarify the accounting by lessors for variable payments that related to both a lease component and a nonlease component. In January 2019, the FASB issued ASU No. 2019-01, Leases Codification Improvements, which reinstates the exception for lessors that are not manufacturers or dealers for determining fair value of the leased property as the underlying asset’s cost, clarifies the presentation on the statement of cash flows for sales type and direct financing leases for lessors that are depository and lending institutions and clarifies the transition disclosures related to accounting changes and error corrections in the year of adoption of the ASU. This update is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This ASU requires timelier recording of credit losses on loans and other financial instruments held. Instead of reserves based on a current probability analysis, ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. All organizations will now use forward-looking information to better inform their credit loss estimates. ASU 2016-13 requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. These disclosures include qualitative and quantitative requirements that provide information about the amounts recorded in the financial statements. In addition, ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. This standard is effective for the Company’s fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the effect the new standard will have on its financial statements.

 

In June 2018, the FASB issued ASU No. 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of costs. The ASU specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. This standard is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.

 

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this ASU modify the disclosure requirements on fair value measurements removing the requirements to disclosure amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. In addition, it modified certain disclosures related to Level 3 fair value measurements and added additional disclosures regarding the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements and the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period. This update is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this update to have a material impact on its financial statements.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Assets for Lease, net (Tables)
 3 Months Ended
Mar. 31, 2019
Leases, Capital [Abstract]  
Schedule of assets for lease
    March 31, 
2019		     December 31, 
2018		  
             
Assets for lease   $ 2,568     $ 2,218  
Less: accumulated depreciation     (1,050 )     (975 )
Assets for lease, net   $ 1,518     $ 1,243  
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Property and Equipment, net (Tables)
 3 Months Ended
Mar. 31, 2019
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment, net
    March 31, 
2019		     December 31, 
2018		  
             
Capital assets   $ 488     $ 457  
Less: accumulated depreciation     (268 )     (234 )
Capital assets, net   $ 220     $ 223  
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Accrued Expenses (Tables)
 3 Months Ended
Mar. 31, 2019
Accrued Liabilities, Current [Abstract]  
Schedule of accrued expenses
    March 31, 
2019		     December 31, 
2018		  
             
Compensation   $ 1,450     $ 2,442  
Miscellaneous accruals     356       355  
Total accrued expenses   $ 1,806     $ 2,797  
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Stock Option Plan (Tables)
 3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of stock option activity
    Options Outstanding  
    Number of
Stock Options
Outstanding		     Weighted
Average
Exercise Price		     Weighted
Average
Remaining
Contractual
Term (In Years)		     Aggregate
Intrinsic Value
 (in thousands)		  
Balance, January 1, 2019     1,761,447     $ 3.18       6.84     $ 55,000  
Options exercised     (6,162 )     2.10                  
Balance, March 31, 2019     1,755,285     $ 3.18       6.59     $ 69,492  
Exercisable as of March 31, 2019     1,554,102     $ 2.99       6.41     $ 61,827  
Schedule of weighted-average Black-Scholes fair value assumptions
    Three months ended March 31,  
    2019     2018  
             
Expected term (in years)     -     5  
Risk-free interest rate     - %     2.2 %
Expected volatility     - %     0.99 %
Expected dividend rate     - %     - %
Schedule of stock-based compensation
    Three months ended March 31,  
    2019     2018  
Cost of Revenue   $ 1     $ 1  
Engineering and Product Development     7       8  
Sales and Marketing     15       29  
General and Administrative     75       155  
Total   $ 98     $ 193  
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Net Income Per Share, Basic and Diluted (Tables)
 3 Months Ended
Mar. 31, 2019
Earnings Per Share [Abstract]  
Schedule of basic and diluted net EPS
    Three months ended March 31,  
    2019     2018  
    Shares     Net Income     EPS     Shares     Net Income     EPS  
Basic EPS     6,326,149     $ 1,854     $ 0.29       5,924,701     $ 706     $ 0.12  
Common stock warrants     246,843       -               225,154       -          
Common stock options     1,597,295       -               1,130,637       -          
Diluted EPS     8,170,287     $ 1,854     $ 0.23       7,280,492     $ 706     $ 0.10  
Schedule of weighted average shares outstanding excluded from the computation of diluted net loss per share
    Three months ended
March 31,		  
    2019     2018  
Weighted average shares outstanding:            
Common stock warrants     -       71,500  
Options     -       135,000  
Total     -       206,500  
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Basis of Presentation (Detail Textuals) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Accounting Policies [Abstract]    
Revenue recognition under variable license fee contracts $ 1,500 $ 750
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Assets for Lease, net - Summary of assets for lease (Details) - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Leases, Capital [Abstract]    
Assets for lease $ 2,568 $ 2,218
Less: accumulated depreciation (1,050) (975)
Assets for lease, net $ 1,518 $ 1,243
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Assets for Lease, net (Detail Textuals) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Leases, Capital [Abstract]    
Depreciation expense $ 109 $ 87
Reduction to accumulated depreciation for returned items 35 33
Loss on disposal of assets for lease $ (34) $ (69)
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Property and Equipment, net (Details) - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Property, Plant and Equipment [Abstract]    
Capital assets $ 488 $ 457
Less: accumulated depreciation (268) (234)
Capital assets, net $ 220 $ 223
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.19.1
Property and Equipment, net (Detail Textuals) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Property, Plant and Equipment [Abstract]    
Depreciation expense $ 34 $ 24
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.19.1
Accrued Expenses - Summary of accrued expenses (Details) - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Accrued Liabilities, Current [Abstract]    
Compensation $ 1,450 $ 2,442
Miscellaneous accruals 356 355
Total accrued expenses $ 1,806 $ 2,797
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.19.1
Concentration of Credit Risk (Detail Textuals)
 3 Months Ended 12 Months Ended
Mar. 31, 2019
Customer
Vendor
Mar. 31, 2018
Customer
Dec. 31, 2018
Customer
Vendor
Customer concentration risk | Revenue      
Concentration Risk [Line Items]      
Number of customers 2 2  
Customer concentration risk | Revenue | Customer one      
Concentration Risk [Line Items]      
Concentration risk percentage 55.60% 58.20%  
Customer concentration risk | Revenue | Customer two      
Concentration Risk [Line Items]      
Concentration risk percentage 12.50% 11.90%  
Customer concentration risk | Accounts receivable      
Concentration Risk [Line Items]      
Number of customers 2   2
Customer concentration risk | Accounts receivable | Customer one      
Concentration Risk [Line Items]      
Concentration risk percentage 41.80%   43.50%
Customer concentration risk | Accounts receivable | Customer two      
Concentration Risk [Line Items]      
Concentration risk percentage 22.30%   40.40%
Vendor concentration risk | Accounts payable      
Concentration Risk [Line Items]      
Number of vendors | Vendor 3   2
Vendor concentration risk | Accounts payable | Vendor one      
Concentration Risk [Line Items]      
Concentration risk percentage 23.30%   11.00%
Vendor concentration risk | Accounts payable | Vendor two      
Concentration Risk [Line Items]      
Concentration risk percentage 20.30%   10.80%
Vendor concentration risk | Accounts payable | Vendor three      
Concentration Risk [Line Items]      
Concentration risk percentage 11.10%    
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies (Detail Textuals) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Loans Payable [Abstract]    
Facilities lease expenses $ 17 $ 17
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Stock Option Plan - Summary of stock-based compensation activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Number of Stock Options Outstanding      
Balance, Beginning 1,761,447    
Options exercised (6,162)    
Balance, Ending 1,755,285    
Exercisable, Ending 1,554,102    
Weighted Average Exercise Price      
Balance, Beginning $ 3.18    
Options exercised 2.10    
Balance, Ending 3.18    
Exercisable, Ending $ 2.99    
Weighted Average Remaining Contractual Term, Options Outstanding (in years) 6 years 7 months 2 days 6 years 10 months 2 days  
Weighted Average Remaining Contractual Term, Options Exercisable (in years) 6 years 4 months 28 days    
Aggregate Intrinsic Value, Options Outstanding $ 69,492   $ 55,000
Aggregate Intrinsic Value, Options Exercisable $ 61,827    
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Stock Option Plan - Weighted-average Black-Scholes fair value assumptions (Details 1)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]    
Expected term (in years)   5 years
Risk free interest rate 0.00% 2.20%
Expected volatility 0.00% 0.99%
Expected dividend rate 0.00% 0.00%
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Stock Option Plan - Stock-based compensation (Details 2) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense $ 98 $ 193
Cost of Revenue    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 1 1
Engineering and Product Development    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 7 8
Sales and Marketing    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 15 29
General and Administrative    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense $ 75 $ 155
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Stock Option Plan (Detail Textuals) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended
Jan. 02, 2018
Jan. 31, 2018
Jan. 31, 2017
Jan. 31, 2016
Oct. 31, 2015
Jan. 31, 2015
Mar. 31, 2019
Mar. 31, 2018
Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Total unrecognized compensation cost related to non-vested stock options             $ 693    
Weighted average period of unvested stock awards             1 year 3 months 29 days    
Weighted average grant date fair value of options granted               $ 5.97  
Aggregate grant date fair value               $ 806  
One-time expense               49  
Stock-based compensation expense             $ 98 $ 193  
Number of stock option granted               135,000  
2007 Key Person Stock Option Plan | Stock options                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares available for future stock-based compensation grants             0    
Maximum number of shares issued pursuant to awards granted under plan             407,500    
2014 Stock Incentive Plan | Stock options                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares available for future stock-based compensation grants             987,337    
Maximum number of shares issued pursuant to awards granted under plan             2,783,616   450,000
Maximum term of stock option grants         10 years        
Number of share reserve increased   235,090 204,943 204,943 1,500,000 188,640      
Percentage of shares reserve increased   4.00% 4.00% 4.00% 4.00% 4.00%      
2014 Stock Incentive Plan | Stock options | CEO                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares available for future stock-based compensation grants 125,000                
Percentage of shares vested on one year anniversary 25.00%                
Number of years in options fully vested 4 years                
2014 Stock Incentive Plan | Stock options | Non Employee Directors                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares available for future stock-based compensation grants 5,000                
Maximum number of shares issued pursuant to awards granted under plan 10,000                
Number of years in options fully vested 1 year                
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.19.1
Net Income Per Share, Basic and Diluted (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Earnings Per Share [Abstract]    
Basic EPS (in shares) 6,326,149 5,924,701
Common stock warrants (in shares) 246,843 225,154
Common stock options (in shares) 1,597,295 1,130,637
Diluted EPS (in shares) 8,170,287 7,280,492
Net Income - Basic EPS $ 1,854 $ 706
Net Income - Common stock warrants 0 0
Net Income - Common stock options 0 0
Net Income - Diluted EPS $ 1,854 $ 706
Basic EPS (in dollars per share) $ 0.29 $ 0.12
Diluted EPS (in dollars per share) $ 0.23 $ 0.10
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.19.1
Net Income Per Share, Basic and Diluted (Details 1) - shares
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Weighted average shares outstanding:    
Total 0 206,500
Common stock warrants    
Weighted average shares outstanding:    
Total 0 71,500
Options    
Weighted average shares outstanding:    
Total 0 135,000
EXCEL 45 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 47 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 48 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 72 148 1 false 25 0 false 6 false false R1.htm 001 - Document - Document and Entity Information Sheet http://semlerscientific.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - Condensed Statements of Income (Unaudited) Sheet http://semlerscientific.com/role/CondensedStatementsOfIncomeUnaudited Condensed Statements of Income (Unaudited) Statements 2 false false R3.htm 003 - Statement - Condensed Balance Sheets Sheet http://semlerscientific.com/role/CondensedBalanceSheets Condensed Balance Sheets Statements 3 false false R4.htm 004 - Statement - Condensed Balance Sheets (Parentheticals) Sheet http://semlerscientific.com/role/CondensedBalanceSheetsParentheticals Condensed Balance Sheets (Parentheticals) Statements 4 false false R5.htm 005 - Statement - Statements of Stockholders' Equity (Deficit) Sheet http://semlerscientific.com/role/StatementsOfStockholdersEquityDeficit Statements of Stockholders' Equity (Deficit) Statements 5 false false R6.htm 006 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://semlerscientific.com/role/CondensedStatementsOfCashFlowsUnaudited Condensed Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 007 - Disclosure - Basis of Presentation Sheet http://semlerscientific.com/role/BasisOfPresentation Basis of Presentation Notes 7 false false R8.htm 009 - Disclosure - Assets for Lease, net Sheet http://semlerscientific.com/role/AssetsForLeaseNet Assets for Lease, net Notes 8 false false R9.htm 010 - Disclosure - Property and Equipment, net Sheet http://semlerscientific.com/role/PropertyAndEquipmentNet Property and Equipment, net Notes 9 false false R10.htm 011 - Disclosure - Accrued Expenses Sheet http://semlerscientific.com/role/AccruedExpenses Accrued Expenses Notes 10 false false R11.htm 012 - Disclosure - Concentration of Credit Risk Sheet http://semlerscientific.com/role/ConcentrationOfCreditRisk Concentration of Credit Risk Notes 11 false false R12.htm 013 - Disclosure - Commitments and Contingencies Sheet http://semlerscientific.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 014 - Disclosure - Stock Option Plan Sheet http://semlerscientific.com/role/StockOptionPlan Stock Option Plan Notes 13 false false R14.htm 015 - Disclosure - Net Income Per Share, Basic and Diluted Sheet http://semlerscientific.com/role/NetLossPerShareBasicAndDiluted Net Income Per Share, Basic and Diluted Notes 14 false false R15.htm 016 - Disclosure - Summary of Significant Accounting Policies and Estimates (Policies) Sheet http://semlerscientific.com/role/SummaryofSignificantAccountingPoliciesandEstimatesPolicies Summary of Significant Accounting Policies and Estimates (Policies) Policies 15 false false R16.htm 017 - Disclosure - Assets for Lease, net (Tables) Sheet http://semlerscientific.com/role/AssetsForLeaseNetTables Assets for Lease, net (Tables) Tables http://semlerscientific.com/role/AssetsForLeaseNet 16 false false R17.htm 018 - Disclosure - Property and Equipment, net (Tables) Sheet http://semlerscientific.com/role/PropertyAndEquipmentNetTables Property and Equipment, net (Tables) Tables http://semlerscientific.com/role/PropertyAndEquipmentNet 17 false false R18.htm 019 - Disclosure - Accrued Expenses (Tables) Sheet http://semlerscientific.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://semlerscientific.com/role/AccruedExpenses 18 false false R19.htm 021 - Disclosure - Stock Option Plan (Tables) Sheet http://semlerscientific.com/role/StockOptionPlanTables Stock Option Plan (Tables) Tables http://semlerscientific.com/role/StockOptionPlan 19 false false R20.htm 022 - Disclosure - Net Income Per Share, Basic and Diluted (Tables) Sheet http://semlerscientific.com/role/NetlosspersharebasicanddilutedTables Net Income Per Share, Basic and Diluted (Tables) Tables http://semlerscientific.com/role/NetLossPerShareBasicAndDiluted 20 false false R21.htm 023 - Disclosure - Basis of Presentation (Detail Textuals) Sheet http://semlerscientific.com/role/BasisOfPresentationDetailTextuals Basis of Presentation (Detail Textuals) Details http://semlerscientific.com/role/BasisOfPresentation 21 false false R22.htm 024 - Disclosure - Assets for Lease, net - Summary of assets for lease (Details) Sheet http://semlerscientific.com/role/AssetsForLeaseNetSummaryOfAssetsForLeaseDetails Assets for Lease, net - Summary of assets for lease (Details) Details 22 false false R23.htm 025 - Disclosure - Assets for Lease, net (Detail Textuals) Sheet http://semlerscientific.com/role/AssetsForLeaseNetDetailTextuals Assets for Lease, net (Detail Textuals) Details http://semlerscientific.com/role/AssetsForLeaseNetTables 23 false false R24.htm 026 - Disclosure - Property and Equipment, net (Details) Sheet http://semlerscientific.com/role/PropertyAndEquipmentNetDetails Property and Equipment, net (Details) Details http://semlerscientific.com/role/PropertyAndEquipmentNetTables 24 false false R25.htm 027 - Disclosure - Property and Equipment, net (Detail Textuals) Sheet http://semlerscientific.com/role/PropertyAndEquipmentNetDetailTextuals Property and Equipment, net (Detail Textuals) Details http://semlerscientific.com/role/PropertyAndEquipmentNetTables 25 false false R26.htm 028 - Disclosure - Accrued Expenses - Summary of accrued expenses (Details) Sheet http://semlerscientific.com/role/AccruedExpensesSummaryOfAccruedExpensesDetails Accrued Expenses - Summary of accrued expenses (Details) Details 26 false false R27.htm 030 - Disclosure - Concentration of Credit Risk (Detail Textuals) Sheet http://semlerscientific.com/role/ConcentrationOfCreditRiskDetailTextuals Concentration of Credit Risk (Detail Textuals) Details http://semlerscientific.com/role/ConcentrationOfCreditRisk 27 false false R28.htm 031 - Disclosure - Commitments and Contingencies (Detail Textuals) Sheet http://semlerscientific.com/role/CommitmentsAndContingenciesDetailsTextuals Commitments and Contingencies (Detail Textuals) Details http://semlerscientific.com/role/CommitmentsAndContingencies 28 false false R29.htm 032 - Disclosure - Stock Option Plan - Summary of stock-based compensation activity (Details) Sheet http://semlerscientific.com/role/StockOptionPlanSummaryOfStockBasedCompensationActivityDetails Stock Option Plan - Summary of stock-based compensation activity (Details) Details 29 false false R30.htm 033 - Disclosure - Stock Option Plan - Weighted-average Black-Scholes fair value assumptions (Details 1) Sheet http://semlerscientific.com/role/StockOptionPlanWeightedAverageBlackScholesFairValueAssumptionsDetails1 Stock Option Plan - Weighted-average Black-Scholes fair value assumptions (Details 1) Details 30 false false R31.htm 034 - Disclosure - Stock Option Plan - Stock-based compensation (Details 2) Sheet http://semlerscientific.com/role/StockOptionPlanStockBasedCompensationDetails2 Stock Option Plan - Stock-based compensation (Details 2) Details 31 false false R32.htm 035 - Disclosure - Stock Option Plan (Detail Textuals) Sheet http://semlerscientific.com/role/StockOptionPlanDetailTextuals Stock Option Plan (Detail Textuals) Details http://semlerscientific.com/role/StockOptionPlanTables 32 false false R33.htm 036 - Disclosure - Net Income Per Share, Basic and Diluted (Details) Sheet http://semlerscientific.com/role/NetLossPerCommonShareDetails Net Income Per Share, Basic and Diluted (Details) Details http://semlerscientific.com/role/NetlosspersharebasicanddilutedTables 33 false false R34.htm 037 - Disclosure - Net Income Per Share, Basic and Diluted (Details 1) Sheet http://semlerscientific.com/role/NetLossPerCommonShareDetails1 Net Income Per Share, Basic and Diluted (Details 1) Details http://semlerscientific.com/role/NetlosspersharebasicanddilutedTables 34 false false All Reports Book All Reports smlr-20190331.xml smlr-20190331.xsd smlr-20190331_cal.xml smlr-20190331_def.xml smlr-20190331_lab.xml smlr-20190331_pre.xml http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 true true ZIP 50 0001144204-19-024259-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-19-024259-xbrl.zip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